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Historically, the transgender community has been treated and studied myopically, using 
the lens of psychological illness. As treatment and research efforts have expanded in the 
past decade, the transgender population is becoming better understood. The purpose of 
the study was to examine the relationship between perceived health and preventative care 
in the transgender community. The health belief model was the theoretical framework for 
this cross-sectional study, which included data from the 2014–2018 Behavioral Risk 
Factor Surveillance System Survey. Chi-square tests and binomial logistic regressions 
were performed to investigate associations between perceived health and preventative 
care in the transgender community. The results revealed a significant association between 
the cisgender group and influenza vaccination status (p = .033) and between male to 
female (MtF) individuals and pneumonia vaccinations (OR = 2.231, 95% CI = 1.182-
4.211), respectively. Further, chi-square results showed a significant association between 
female to male (FtM) individuals and the following diseases, arthritis (p = .001), 
depressive disorder (p = .009), and diabetes (p = .045). This project supports positive 
social change by helping healthcare professionals better understand the specific 
preventative healthcare needs in the subgroups of the transgender community and to 
design customized preventative programs for them. 
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Section 1: Foundation of the Study and Literature Review  
In the past decade, the available literature on transgender people has grown; 
however, it was still scarce when these individuals perceived health and preventative care 
was explicitly addressed because this was an emerging demographic group. The literature 
focused on the treatment aspect and refining processes and procedures. The National 
Institutes of Health (NIH) has funded numerous studies on the transgender population; 
but primarily focused on HIV status, psychological distress, and risky health behaviors 
(Coulter et al., 2014; Downing & Przedworski, 2018). The literature was more robust 
when defining the current health and health outcomes of transgender and cisgender 
populations with a caution that the numbers were relatively low and may underrepresent 
this population (Meerwijk & Sevelius, 2017). 
Historically, transgender persons were not uniquely identified and were only 
substantively chronicled for analysis since roughly 2006 (Meerwijk & Sevelius, 2017). 
The notion of “gender,” at its genesis, was distinguished from the conventional notion of 
sex and represented the social, emotional, and psychological differences people faced, 
including how people understood these differences between men and women in a cultural 
context, not based on biology (Lambert, 2019). Initially conflated with homosexuality 
(Ulrichs, 1864), transgenderism became a more well-defined population in the mid-
1950s. Karl Ulrichs was a pioneer in defining homosexual behavior and, in doing so, 
defined the transgender population as well (Kennedy, 2002). From Ulrich's publications 
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in the 1860s and over the next century, the lexicon became more nuanced and specific 
terms became associated with the transgender population as they became better defined. 
As the transgender population became more clearly defined, specific 
psychological and physical health outcomes and behaviors were researched and became 
more evident; this warrants further investigation. The transgender community has a wide 
variety of needs, including hormone treatment, mental health services, and sex-
confirming surgery (Arora et al., 2020). These services focus on long-term solutions, 
potentially lasting a lifetime (Meyer et al., 2020); once a decision is made, there is no 
routinely successful path to reversing it. Making these decisions to undergo treatments 
makes for some tough decisions that impact the individual, their family and friends, and 
the underlying relationships they have with each of those people. However, critical 
components reported as part of long-term success, such as health, and renormalization of 
relationships after surgeries, include all of the factors listed above (Ruppin & Pfäfflin, 
2015). 
There is evidence of a relationship between transgender thoughts and feelings in 
individuals and white matter microstructure in the brain; however, there is no definitive 
evidence that transgenderism is congenital, learned behavior, or possibly both (Kreukels 
& Guillamon, 2016). Additional research suggests one of the different possibilities for a 
medical explanation of transgenderism includes genetic expression (Fernandez et al., 
2018). Nevertheless, most researchers believe there is no clear correlation between a 
medical genesis and being transgender (Foreman et al., 2018). More research is needed to 
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support the overall understanding of the transgender population and the medical 
community's ability to meet its needs. 
In defining the medical and public health needs of the transgender community, 
Cruz (as cited in Lerner & Robles, 2017) discovered that perceived barriers to care 
prohibited the transgender population from pursuing healthcare at a rate two-and-a-half 
times greater than the cisgender population. Downing and Przedworski (2018) reported 
that the transgender population performed poorly in many health outcomes historically 
associated with some type of preventative medicine. However, the authors drew no 
comparison on perceived barriers to, and actions to seek preventative care because they 
focused on the current state of transgender care, including health services, health 
behaviors, and quality of life. More information is needed to improve transgender 
healthcare and fill the gap in the literature on potential differences between the cisgender 
and transgender populations in their perceptions of barriers to care and the impact of 
those barriers on pursuing preventative health care. Not dissimilar to other diagnostic 
research groups, the transgender population is relatively new and requires targeted 
treatment to address their specific population health and individual medical needs. 
Additionally, there is a marked disadvantage in treating the transgender population, as the 




Nature of the Study 
This quantitative cross-sectional study investigated data from adult participants, 
aged 18 and older, in a national study. It explored potential differences in perceived 
health and the receipt of preventative care (such as a mammogram, PAP. test, influenza 
vaccination, pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and cisgender adults in the United 
States. The independent variable was the type of the population (transgender/cisgender); 
the dependent variables were perceived health and received preventative care, and the 
control variables were the population demographics. Examining transgender persons' 
behaviors relative to current health perceptions identified potential differences between 
the transgender and cisgender groups and any difference from within the transgender 
population.  
Characterizing the transgender population was a difficult task. There were no 
current standardized demographic data on transgender individuals (Trinh et al., 2017). 
The most widely accepted estimation was roughly 1 million individuals in the U.S., or 
0.3% of the population (Stroumsa, 2014). Researchers noted that the number of 
individuals with gender identity disorder in a Veterans Administration sample of U.S. 
veterans nearly doubled over a ten year period from 2000 to 2010; however, the 
researchers believed that the actual number of individuals in the transgender sample was 
low, suggesting underreporting (Blosnich et al., 2013). Conflated terms and taxonomy 
still retarded the ability to clarify the definition of transgender (Stroumsa, 2014). Since 
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this characterization has been a significant issue, even the above number of transgender 
individuals was highly contested (Blosnich et al., 2013). 
Research Questions and Hypotheses 
The purpose of this study was to investigate whether there were any differences in 
the transgender and non-transgender populations regarding perceived health and receipt 
of preventative care while controlling for demographics. 
RQ1: Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in the 
U.S.? 
H01: There is no significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in 
the U.S. 
Ha1: There is a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 




Independent variable: being transgender (yes/no). 
Dependent variables: perceived health and receipt of preventative care. 
Control variables: age, race/ethnicity, income 
RQ2: Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and female-to-
male (FtM) transgender adults? 
H02: There is no significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and 
female-to-male (FtM) transgender adults. 
Ha2: There is a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and 
female-to-male (FtM) transgender adults. 
Independent variable: transgender type [male-to-female (MtF)/female-to-male 
(FtM)] 
Dependent variables: perceived health and receipt of preventative care. 
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Control variables: age, race/ethnicity, income 
RQ3: Quantitative: Are there significant differences between the MtF and FtM 
transgender adults in the frequency of medical treatments pursued by those with 
substantial chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS)? 
H03: There are no significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial 
chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS). 
Ha3: There are significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial 
chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS). 
Independent variable: transgender type [male-to-female (MtF)/female-to-male 
(FtM)] 
Dependent variable: frequency of medical treatments. 
Control variables: age, race/ethnicity, income 
RQ4: Quantitative: In the adult population, is there a significant difference 
regarding perceived satisfaction of care and the number of medical appointments 




H04: There is no significant difference regarding perceived satisfaction of care 
and the number of medical appointments conducted between MtF transgender, the 
FtM transgender, and the non-transgender communities. 
Ha4: There is a significant difference regarding perceived satisfaction of care and 
the number of medical appointments conducted between MtF transgender, the 
FtM transgender, and the non-transgender communities. 
Independent variable: transgender status (MtF transgender, the FtM transgender, 
non-transgender) 
Dependent variables: perceived satisfaction of care and the number of medical 
appointments. 
Control variables: age, race/ethnicity, income 
Literature Search Strategy 
Six databases were analyzed (PubMed, Medline, SocIndex, CINAHL Plus, 
Google Scholar, and ScholarWorks) to identify scholarly works for review. Keywords 
were used in the analysis, meta-analyses, and references to help find and search within 
pertinent literature for the most relevant information to the subject matter. Searches were 
limited to the years 2015-2021. During the research, older works were discovered, 
reviewed, and cited as they are still the authoritative documents in the field. 
All keywords were used in combinations with each other and with more general 
terms. The keywords used in this literature review were transgender, transsexual, 
transexual, non-gender specific, gender, gender fluid, variant, minority, gender non-
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binary, cisgender, perception, perceived health, preventative care, determinants, 
nonbinary, sex, natal, insurance, ethics, access, and health outcomes.  
Literature Review 
In this subsection, the literature on transgender and cisgender people in the U.S.; 
their individual perceived health status, accurate reporting of transgender persons in 
research and surveys, current research, and understanding of the genesis of 
transgenderism, determinants of health and health outcomes was examined. Additionally, 
numerous covariates were researched, including ethics, fiduciary barriers, HIV/AIDS, 
substance abuse, religion, and access to medical care. Finally, gaps in the research were 
illuminated that focused on transgender peoples' perceived health status and their actions 
relative to seeking preventative care. 
Transgender  and Cisgender  Population Datasets 
There were some noticeable differences between the transgender and cisgender 
populations. There were relatively few datasets available to study the data at a national 
level from the general population; this was a literature gap little addressed that needed 
further investigation (Institute, 2011). Several state-level studies were identified as well 
as ones from other countries; however, their use was sparing because the focus of this 
research was for data collected for U.S. adults at a national level. Given these 
predetermined limitations, few papers in the research databases focused on analyzing this 
diagnostic research group of transgender people. 
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Meerwijk and Sevelius (2017) conducted the first broadscale meta-analysis 
identifying national-level studies, which included the transgender category making it a 
gender identity study contrasting with a traditional binary gender data collection and only 
included the questioning of sexual orientation. Meerwijk and Sevelius (2017) identified 
three qualifying sources for their data; they included the Behavioral Risk Factor 
Surveillance System (BRFSS) with two datasets, National College Health Assessment 
with eight datasets, and the National Inmate Survey with three datasets. Each of the 
studies mentioned above was an annual data collection (2017). In 2018, Downing and 
Przedworski conducted the first comprehensive large sample investigation into current 
transgender health conditions and prospects for improving health outcomes. Three years 
of data were examined by Downing and Przedworski, which included 525,301 
respondents containing 0.48% (95% CI = 0.44, 0.53) identifying as transgender (2018). 
Transgender Perceived Health 
There was limited literature regarding the transgender population's perception of 
their health; however, research efforts gauged perceptions of several different groups of 
individuals. Approximately half of the known transgender population delayed getting 
needed healthcare; the cisgender population only delayed at a rate of roughly 20%; this 
lack of transgender people seeking care was related to perceived barriers to treatment 
(Cruz, as cited in Lerner & Robles, 2017). Additionally, there was a link between a 
transgender persons' high level of depression and their perception of expected domestic 
abuse and personal injury (Owen-Smith et al., 2017). 
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A study of providers regarding transgender youth health illuminated provider 
perceptions that transcend age; most providers understood the term transgender was 
congruent with homosexuality and mistakenly conflated the two terms (Lefkowitz & 
Mannell, 2017). This misconception was a theme that needed delineation as transgender 
persons were of gender identity, and homosexuals were of sexual orientation. 
These groups of people, both transgender and homosexual, relied on different 
social support structures. Regarding transgender individuals, their perceived level of 
attributed stigma due to misgendering required low social support levels; however, as 
their perception of misgendering became more frequent, their social support needs 
likewise increased (McLemore, 2018). Mitigating the social support needs has proven to 
reduce barriers to care and has been beneficial in stigma reduction and negative 
perceptions in the transgender population (Holt et al., 2019; Reisner et al., 2017). 
Accurate Reporting of Transgender Population in Research and Surveys 
Discerning an accurate representation of transgender people in any specific 
population has been difficult (Meerwijk & Sevelius, 2017) and required focus in two 
specific areas of data collection. Frequently, the transgender population was researched 
as a disease outcome in public health and epidemiological investigations, most 
specifically in the case of HIV (Dinno et al., 2013), and not as a distinct and exclusive 
population. This myopic approach made accurately accounting for the overall population 




Secondly, the accurate categorization of people within the transgender community 
was problematic. One available solution for a statistical standard was from New Zealand 
and comprehensively addressed the gender identity questions facing individuals (Pega et 
al., 2017). This solution was versatile in that it considered the fluidity of gender identity 
because it allowed for change over time (Pega et al., 2017; Statistical standard, 2015). 
Potential Etiology of Transgenderism 
The belief to date was that the etiology of gender dysphoria was still 
undetermined (Foreman et al., 2018). Gender dysphoria is the feeling a person 
experiences when their psychological and social expression of identity does not align 
with their natal sex (American Psychiatric Association, 2013). Literature investigating the 
genetic aspect of gender identity illuminates concordance of a higher rate with 
monozygotic as opposed to dizygotic twins in both MtF (Male-to-Female) and FtM 
(Female-to-Male) people (Heylens et al., 2012), this pointed to a genetic basis in 
underlying gender incongruent development. There was evidence that polymorphism 
associated with the roles of androgen receptor (AR), estrogen receptors alpha (ERα) and 
beta (ERβ), and aromatase (CYP19A1) were implicit in the genetic aspect related to 
gender identity and gene expression (Fernández et al., 2018). These bodies of research 
suggested that sex hormone signaling had an oligogenic component as gene expression of 
a few genes had an enormous impact on gender identification. Research also supported 
that sexual distinction in the brain, and the genitals developed at different times; in the 
brain, this developed before it did in the genitals, making it feasible there could have 
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been a difference (Roselli, 2018). Additionally, when testosterone was introduced in 
female rats within a short time after birth, they presented with masculine traits (McCarthy 
et al., 2012); in humans, a prenatal nontypical introduction to hormones changed the 
gender identity in some and sexual orientation in others, but this was the minority 
response (Roselli, 2018). 
However, it was not just that the manner of genetic expression; an essential 
component includes the genotype, specifically the ERβ, ERα and AR, and their allele as 
crucial in the categorical identification and prediction of gender identity probability 
(Fernández et al., 2018) that was important. Additional information explained that global 
haplotype, a set of DNA polymorphisms, was prevalent amongst FtM (p = .017); 
however, it was not a factor in MtF individuals (Cortés-Cortés et al., 2017; Zubiaurre-
Elorza et al., 2013) researched twins and found that 23-33% of monozygotic twin pairs in 
the study were concordant for gender dysphoria, further suggesting a genetic component 
(Foreman et al., 2018). 
Brain development was another potential location where science could identify 
the etiology of gender dysphoria. Additional investigations by Kreukels and Guillamon 
(2016) revealed through neuroimaging that specific regions in the brains of MtF people 
appeared more similar to the brains of women as opposed to that of a man. This research 
was consistent with Hoekzema et al. (2015), based on the specificity of the location of the 
volume of gray matter. However, there was one stark contrast, Hoekzema et al. (2015) 
found that through voxel-based morphometry, the left superior medial frontal cortex 
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displayed a larger volume of gray matter in FtM people, making them consistent with 
findings of the control group of their natal sex. Furthermore, boys displayed more gray 
matter in the bilateral superior posterior hemispheres of the cerebellum and the 
hypothalamus; this was consistent with MtF people making both sexes and both gender 
dysphoric groups consistent with gray matter volume of their natal sex (Hoekzema et al., 
2015). Shiino et al. (2017) recorded a statistically significant difference in regionally 
specific white matter and corpus callosum based on the bivariate of sex. Mueller et al. 
(2017) achieved similar results, noting that results were specific to subtype in the 
demographic group and were not the same or consistent outside groups. 
History and Demographics of the Transgender Population 
Historically, the transgender and homosexual populations were considered the 
same (Ulrichs, 1864). It was only recently that researchers and clinicians acknowledged a 
clear differentiation between the populations; this new mindset started in the mid-1950s. 
Transgenderism was defined only as gender dysphoria for years; this was not a correct 
depiction of the population as there was information that suggested there were many 
contributing factors that influence gender expression and that it was not just a mental 
illness or disorder (Joseph et al., 2017). 
Another inhibitor to understanding and medically treating the transgender 
population was the fundamental comprehension of the number of transgender people as 
most survey tools did not capture the data for years. It has only been within the past ten 
years that researchers started to more comprehensively measure the transgender 
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population because, for decades, the number of transgender people was misjudged too 
low (Marshall, 2017). 
Discerning an accurate representation of transgender people in any specific 
population has been difficult (Meerwijk & Sevelius, 2017). It was estimated by Crissman, 
et al. (2017) that transgender people comprise 0.53% (95% confidence interval [CI] = 
0.46, 0.61) of the U.S. population. The calculations from Flores et al. (2016) estimated a 
bit higher; the transgender adult population in the U.S. was roughly 560 per 100,000, 
which translated to 0.6% of the adult population. The data they used came from the 
Behavioral Risk Factor Surveillance System (BRFSS) (Meerwijk & Sevelius, 2017). This 
questionnaire is yearly and is now more widely used, collecting more valuable 
information, including valuable information from transgender adults. Doan (2016) 
suggested a comprehensive methodology was needed to gain an accurate count of the 
transgender population. The BRFSS looked to be a good start in that direction. 
Obtaining an accurate number of transgender people worldwide was difficult as 
some countries acknowledge and count them, others acknowledge and do not count them, 
and still, others did not acknowledge them at all. Other barriers included the basic 
definition of transgender, where the definition could have been people who had 
undergone complete sexual reassignment to those who cross-dressed or identified as 
gender fluid or even intersex (Doan, 2016). Another difficulty in counting the number of 
transgender people was in the definition people assign to themselves as some transgender 
people did not refer to themselves as transgender; they only referred to themselves by 
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their assumed gender and never referred to themselves by their natal gender (Meier & 
Labuski, 2013a). In some countries, identification as transgender was illegal, and some 
transgender people feared for their lives if anyone found out their gender identity (Kritz, 
2014). 
In 2013b, Meier and Labuski conducted a broad calculation of data collected from 
18 different countries to date focused on transgender data. The prevalence of transgender 
individuals varied very broadly from country to country, and that was partially because of 
definitions again; however, Meier and Labuski (2013b) reported that if all forms of 
transgenderism were counted in the definition to include everything from cross-dressers 
to completed surgical transitions, the rate would be roughly 1:500. They cautioned that as 
healthcare and diagnostics reforms moved forward, the landscape and numbers could 
change substantially and would be different from what they reported (2013a). 
The Transgender Population and Health Outcomes 
Numerous factors affected people's health and their corresponding health 
outcomes (Office of Disease Prevention and Health Promotion [ODPHP], 2018). Social 
determinants of health covered various environmental, personal, economic, and social 
factors that have impacted health outcomes (ODPHP, 2018). Controlling for these 
variables was essential as health outcomes and behaviors differed by race and 
demographic group (Trinh et al., 2017). General health and health outcomes studies in the 
transgender community had recently increased as only 7% of studies in the six years 
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leading up to 2014 focused on these issues instead of primarily mental health and HIV 
(Downing & Przedworski, 2018). 
Research showed that transgender males had an increased risk for polycythemia, 
potentially for hyperlipidemia, and increased potential for cardiovascular disease and 
hypertension (Rahman & Linsenmeyer, 2019). Gender nonconforming, a group that did 
not comply with traditional definitions of sex and gender, in almost all cases, had the 
least favorable health outcomes. Downing and Przedworski (2018) stated that gender 
nonconforming persons reported the most multiple medical conditions (50.7%) and had 
the highest rates of asthma and depression (19.1% and 38.2%). Gender nonconforming 
also reported the highest category with more than one disability (45.6%) cognitive 
disability and also mental distress (32.2% & 28.1%) (Downing & Przedworski, 2018). 
MtF people had diminished physical functioning (p < 0.001) because of physical health 
issues (p = 0.015) (Valashany & Janghorbani, 2018). However, MtF persons displayed 
disproportionately poorer health outcomes and behaviors in two categories, diabetes 
(14.5%) and had more than one disability (33%) (Downing & Przedworski, 2018). They 
additionally led all other gender categories in heavy episodic drinking (42.6%), lack of 
annual dental visits (47.6%), and obesity (31.3%). Whereas females, on the other hand, 
had an increased risk for venous thromboembolic disease and hypertriglyceridemia as 
well as an increased risk for hypertension (Rahman & Linsenmeyer, 2019). 
All three categories of MtF, FtM, and gender nonconforming reported the reason 
for no primary health care or provider was cost at a rate higher than cisgender 
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participants; they also had the highest rates for having HIV testing done (Downing & 
Przedworski, 2018). Identification that transgender people, regardless of MtF or FtM, 
generally have a lower quality of life than cisgender people with MtF having a lower 
quality of life than FtM persons (Valashany & Janghorbani, 2018) was evident. 
Mental Health 
Rowe et al. (2019) reported that there was a high prevalence of low self-esteem 
amongst transgender people. Many factors may have contributed to these feelings. 
Results of another study demonstrated significant risk factors for worse mental health 
outcomes among FtM transgender individuals, including low income, less education, 
discrimination, and intimate partner violence (McDowell et al., 2019). Poor mental health 
outcomes compound underlying issues. FtM transgender participants with low income 
and limited education were associated with the heightened odds of depression and anxiety 
(McDowell et al., 2019). Freese et al. (2018) identified three predominant coping profiles 
for people and demonstrated in their research the overrepresentation of people in the 
transgender community in coping profiles which had the most significant prevalence of 
dealing with issues in an unhealthy manner, specifically with denial and substance abuse. 
There were several factors associated with positive mental health outcomes 
prevalent in the transgender community. FtM transgender people in good, committed 
relationships who were older and maintained high personal resilience experienced good 
mental health outcomes (McDowell et al., 2019). Additionally, when people perceived a 
FtM transgender person's voice as more masculine, they experienced less depression or 
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anxiety along with several other positive health outcomes (Watt et al., 2018). These 
results were comparable to a similar study in MtF transgender people when others 
perceived their voice as effeminate (Hancock et al., 2011) 
Rodriguez et al. reported that over 50% of the participants in their study received 
a mental health diagnosis associated with their gender (2018). As discrimination is 
associated with poor mental health outcomes (McDowell et al., 2019), it was highly 
ironic that most transgender people faced discrimination at mental health clinics 
(Rodriguez et al., 2018) 
Turban et al. stated that despite an ongoing higher prevalence of mental health 
issues, providers throughout the U.S. had engaged in psychological attempts to change a 
person's gender identity from transgender to cisgender (PACGI) (2019). This practice of 
PACGI was understood as ineffective and unethical and may have long-term effects as 
roughly 5% of transgender patients reported exposure to PACGI from 2010 to 2015 
(Turban et al., 2019). Additionally, the researchers found associations between recalled 
lifetime exposure of attempting to turn a transgender person back to their natal gender 
through counseling and higher odds of lifetime suicide attempts (Turban et al., 2020). 
According to Libman et al., recommendations of clinical practice guidelines for 
treating transgender adults from the Endocrine Society suggested clinicians include a 
mental health professional who was current with transgender needs (2020). Selvaggi and 




Transgender and gender-nonconforming people in the United States face 
disproportionate substance abuse rates than their cisgender counterparts (Safer & 
Tangpricha, 2019; White & Fontenot, 2019). Lombardi (as cited in Rowe et al., 2019) 
reported that nearly 30% of transgender participants abused both legal and illicit drugs at 
a rate three times higher than the cisgender population. Clements-Nolle et al. found (as 
cited in Weir & Piquette, 2018) that 28% of the participants received treatment for 
abusing either drugs or alcohol. Transgender men use cannabis, alcohol, or cocaine at a 
rate four times greater than cisgender men (Nuttbrock et al., 2014b). 
A correlation between substance abuse and violence was also documented 
(Clements-Nolle et al., Testa et al., as cited in Weir & Piquette, 2018). A correlation 
between FtM victims of physical violence experiencing higher alcohol abuse rates (Testa 
et al., as cited in Weir & Piquette, 2018). There was also an association between 
transgender individuals who suffered from sexual abuse with alcohol and illicit drug 
abuse (Nuttbrock et al., 2014a; Testa et al., as cited in Weir & Piquette, 2018). 
Substance abuse in the transgender community was a significant problem, and 
social service counselors help address this issue. Counselors must be more aware of the 
individual and social aspects of the transgender community. Oberheim et al. (2017) 
recommended that counselors address an individual's gender identity and what it meant to 
that person during counseling. This approach allowed for an open session of excellent 




The prevalence of HIV within the transgender population, specifically MtF 
transgender people, was significantly higher than the cisgender population (Gianella et 
al., 2018; Habarta et al., 2015; Martinez et al., 2019). The ODPHP (2019) highlighted 
that the prevalence of HIV in the transgender community was significantly higher than in 
the cisgender population and all other LGBTQ groups. New confirmed cases of HIV 
were at the highest rate in the transgender community (Habarta et al., 2015). 
These points were vital because they illustrated the need for effective prophylaxis 
and associated HIV treatment which focused on the needs of the transgender community 
(Becasen et al., 2019; Gianella et al., 2018; Habarta et al., 2015; Martinez et al., 2019). 
MtF transgender people and men who had sex with men comprise over 50% of 
HIV/AIDS cases existing in the U.S. today (Rowe et al., 2019). According to Becasen et 
al. (2019), the number of MtF transgender people living with HIV is historically 
underestimated. 
To improve awareness, testing, and care for the transgender community, a new 
approach, including personalized treatment programs, was necessary (Pitasi et al., 2020). 
Researchers must do more to understand HIV testing practices within the transgender 
community (Habarta et al., 2015). In one study, the researchers reported that testing for 
HIV did not necessarily lead to or imply patients were aware of their HIV status or 
gained access to treatment and care (Vaitses Fontanari et al., 2019). However, when 
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tested on-site in a clinical setting, MtF transgender people regularly received treatment 
much faster than those not treated on a clinical site (Pitasi et al., 2020). 
Mandsager et al. report that disparities in HIV prevalence between cisgender men 
and transgender individuals are declining (2018). Conversely, Pitasi et al. report that MtF 
transgender individuals in treatment plans fell short of established goals (2020). Martinez 
et al. describe some community efforts that immensely helped match HIV positive 
transgender people with effective treatment options (2019). Mandsager et al. cited 
success in data collected from nine geographically distinct sites equipped to evaluate the 
treatment and long-term care for HIV positive MtF transgender women of color (2018). 
Ethics in Transgender Health 
Drescher and Pula (2014) posed an ethical dilemma; evidence-based medical 
research necessitates comprehensive data that may constrain efforts to address the needs 
of the transgender population clinically. Transgender people, families, and clinicians 
must sometimes make tough ethical without research-based conclusions (Drescher & 
Pula, 2014). How do the community of researchers and medical professionals collect data 
to enable clinicians to provide high-quality care to the transgender community while 
operating within ethical guidelines? Principlism, explained by LaSala and Goldblatt 
Hyatt (2019), embodied the ethical standards and values of factors that were 
predominantly significant to the transgender community when they sought care. Four 




Data suggested that most patients did well post gender-reassignment and that 
adverse outcomes are rare; these data's reliability are weak (D'Angelo, 2018). 
Additionally, as a matter of moral integrity in clinical encounters, informed consent must 
be obtained for body modifications for gender expression, as it must be for any clinical 
intervention (Murphy, 2016). 
Children who were transgender themselves or of transgender parents presented 
some of the most significant ethical issues facing the transgender community. Murphy 
(2018) found that bioethics language, concerning having children in a home, through 
adoption or birth, with one or more transgender parents, intentionally worked against 
status equality for those parents. One detractor for this language may have been a result 
of domestic stability and security. Transgender people experienced a higher prevalence of 
discrimination, mental health issues, and suicide (Casey et al., 2019) related to cisgender 
people. 
Providers must be very cautious and promote a transition in children as the 
research shows a comparatively small percentage of children maintain their new gender, 
most transition back to their natal gender (Drescher & Pula, 2014). 
A problematic ethical issue in children was identifying the facts; a child's desire to 
become transgender may have been one way to deal with severe trauma and may have 
meant the child was not transgender at all (Drescher & Pula, 2014). The correct diagnosis 
was critical for medical providers, and they must ensure, as best they can, that there are 
no changes back to an individual's natal gender later in life. A child's perspective of what 
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defined gender varied according to their age (Drescher & Pula, 2014). To ensure 
nonmaleficence, when a child was permitted gender-confirming surgery, they must 
become aware that there was a high likelihood that they would be left sterile if they return 
to their natal gender (Abel, 2014). However, children who identified as transgender and 
carried that into adolescence were more apt to maintain that identity as adults (Drescher 
& Pula, 2014). 
The primary responsibility and moral obligation of all health care providers was 
in offering a patient the most excellent quality health care they can, and that the basis of 
care must be on a complete and total assessment of a patient's condition (Selvaggi & 
Giordano, 2014). This ethical standard was essential, so clinicians must consider all 
factors when identifying a young person as transgender because it can be difficult without 
first eliminating a myriad of other variables (Drescher & Pula, 2014). Barkai (2017) 
found that an analyst's focus on pathological gender expression was defined subjectively 
by the analyst. Without strict medical and ethical guidelines, there was a higher level of 
potential error. 
Ethically, all providers should seek a holistic approach to transgender care. When 
faced with the request for treatments of unproven effectiveness and safety, mental health 
practitioners must seek counsel from other medical professionals to gain a complete 
understanding of informed consent ethics (Drescher & Pula, 2014). One path to providing 
exceptional care was not to require a transgender individual to participate in mental 
health counseling before reassignment surgery; this approach did not compromise a 
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patient's autonomy (Selvaggi & Giordano, 2014). Historically, psychiatrists tried to cure 
homosexuality; this activity raised the question of whether treating an individual's search 
of one's gender identity was a benevolent activity or an attack on an individual's 
autonomy (Drescher & Pula, 2014). 
Clinicians also have some moral dilemmas when sharing information with 
transgender individuals, but they should present the beneficial and adverse outcomes 
from evidence-based research. The most concerning result of one study was that after 
gender-confirming surgery, the patients had higher rates of mortality and suicide 
compared with the age-matched, cisgender control group (D'Angelo, 2018). Some 
research also offered ethical issues in that drop-out rates for follow-ups were high; this 
resulted in selection bias meaning an underrepresentation of people who had gender 
reassignment surgery because those who believe it was a failure are less likely to follow 
up (D'Angelo, 2018). 
Preventative Health Care 
Defining and prioritizing vital preventative care for transgender people was 
essential. Taksler et al. (2018) found that as the number of recommended preventative 
services for any demographic group increased the compliance with those 
recommendations dropped. A sample of adults in the U.S. over the age of thirty-five 
demonstrated that fewer than 8% had received all top-priority preventative clinical 
services for their demographic group, and almost 5% received no preventative clinical 
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services at all (Borsky et al., 2018). Prioritization within demographic groups of the 
preventative care recommendations might improve the utilization of high-value services. 
Additionally, medical professionals recognized that unique health considerations 
were present in the transgender community. The transgender population was at the 
highest risk for STD because of risky behavior, and prevention was imperative (Qureshi 
et al., 2017). Since there was a lack of prevention, there was a significant prevalence of 
sexually transferred diseases within this population; however, less than half of the 
transgender population report personal testing for STDs (47%), but most (71%) would 
test for STDs at home (McRee et al., 2018). 
The transgender community was exclusive in preventative health care treatment 
for metabolic screening, cancer screening, immunizations, and prophylactic management 
secondary to cross-sex hormone therapy, gender-confirming surgical procedures, and 
other high-risk behaviors prevalent in the population (Imborek et al., 2017). Participation 
in basic preventative services such as an annual exam was just as important; however, 
only 35% acknowledged getting a routine examination (McRee et al., 2018). Preventative 
annual dental services were used even less (OR = 0.7; 95% CI = 0.5, 1.0) (Meyer et al., 
2017). Additionally, information related to the nutrition and diet of the transgender 
population was significant. Researchers must examine diet and focus on the different 
demographic groups instead of the traditional collective diagnostic group analysis for all 
transgender people (Smalley et al., 2016). 
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Because the transgender population had historically been invisible and lacking in 
primary care services, Mayfield and Fancovic (2017) developed a preventative care 
handbook for primary care clinicians who treated transgender or suspected transgender 
patients. Many transgender people did not share their situation with clinicians meaning; 
some transgender people do not refer to themselves as their former gender or choose not 
to share that information with the clinician (Meier & Labuski, 2013a). This secretive 
environment and other factors led to transgender people facing negative experiences in 
preventative health care treatment (Imborek et al., 2017). A patient presents an 
incomplete picture by not sharing information with the provider, and the clinician can 
only treat someone from the information the clinician has available; this has led to an 
incorrect diagnosis, testing, or treatment. 
Historically considered one population, the transgender community had only been 
identified in subgroups, as in any other population, within the last decade. Understanding 
this, we can see that the collective youths' preventative health practices impact adult 
preventative care. When research focusing on transgender young adult’s health 
concentrates on gender-related care while ignoring vital preventative healthcare services 
like annual check-ups and vaccination (McRee et al., 2018), the research community 
should take note and investigate further. 
Violence/Discrimination 
There was a broad range of violence that transgender individuals experience, 
which was affected by determinants of health explicit to the transgender community, 
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including domestic, sexual violence and suicide or self-harm (Dinno, 2017). Being a 
gender minority, the transgender population were the victims of ongoing discrimination. 
Over 90% of gender minority people believed they were discriminated against, while 
another 51% have been the victims of violent episodes against their person (Casey et al., 
2019). Despite this, participants and practitioners both believed that the increased 
availability of comprehensive domestic abuse programs, including resources geared 
towards transgender people, was beneficial (Rogers, 2016). 
As a transgender person sought help from being a victim of violence, they faced 
substantial problems obtaining the appropriate care from the beginning. We saw 
significant levels of depression in the transgender and gender-nonconforming 
communities were associated strongly with an individual's perception of community 
tolerance (Owen-Smith et al., 2017). When someone identified an individual as 
transgender, research showed a significant association with discrimination when trying to 
obtain services from the rape crisis and domestic violence centers as well as other health 
care facilities (Rodriguez et al., 2018). 
The subjectivity of gender identity has also been a factor in perpetuating violence 
focused on the transgender community. In some instances, just the perception of another 
person's gender identity was enough in motivating violence against the transgender 
individual (Blondeel et al., 2018). With substantial domestic and self-violence in the 
transgender community, it was interesting to observe fewer homicides recorded of 
transgender people than the average in the U.S. for the cisgender community (Dinno, 
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2017). However, homicide rates for black or Latina MtF transgender individuals were 
much higher than the national average (Dinno, 2017). 
Suicidal ideation and attempts were seen at higher numbers in the transgender 
population than in the general U.S. population (García-Vega et al., 2018). Understanding 
suicide was essential because, in the transgender population, the prevalence of suicide 
attempts had been cited as high as 41% (Haas et al., 2014), as opposed to less than 9% in 
the general U.S. population (Nock et al., as cited in Perez-Brumer et al., 2015). Tebbe 
and Moradi (2016) assessed the elevated rates of suicide in the transgender community 
using the Minority Stress Theory and concluded factors such as fear of bias, stigma, 
transphobia, and other prejudices were very influential. Additionally, research supported 
that when a transgender individual had extensive exposure to gender identity conversion 
efforts, it was negatively associated with an adult's mental health outcomes (Turban et al., 
2020). The findings were congruent with numerous professional organizations' posture 
that discouraged this practice (Turban et al., 2020). 
Access to Care 
Access to care was a significant issue for anyone, but more so for people in the 
transgender population who face numerous challenges (Kattari et al., 2019). Some 
limitations were created internally by the patient, while others were purely existential. 




First, discrimination may have resulted from social stigma on a person's perceived 
characteristics, including thoughts and behaviors of the transgender community (Cruz, 
2014; Gonzales et al., 2017). These generalizations were dangerous and led not only to a 
limitation of access to healthcare but to more aggressive harassment and victimization of 
targeted individuals (Kattari et al., 2019). In some situations, this discrimination became 
so problematic that healthcare providers and clinicians refused treatment of transgender 
patients (Qureshi et al., 2017). Ongoing fear of discrimination and potential problems 
with office visits by transgender individuals kept significant numbers of patients out of 
their provider's office (Kattari et al., 2019). Providers cited repercussions from their local 
community and lack of education of the population as reasons to refuse treatment 
(Qureshi et al., 2017). 
Coverage, insurance, and, as mentioned above, a provider who understood 
transgender health (Bakko & Kattari, 2019; Dickey et al., 2016; Gonzales et al., 2017; 
Meyer et al., 2017; Qureshi et al., 2017) were some of the additional vital components 
which affected access to care more than any others. Conversely, Seelman et al. (2018) 
found no differences in access to care for transgender men when controlled for 
sociodemographic factors. Gonzales et al. (2017) identified that transgender women had 
less coverage in terms of insurance than cisgender women, and transgender men have less 
coverage than any other group in their research group. 
Providers self-identified the need for enhanced education resources related to the 
unique needs of the transgender community in totality (Arora et al., 2020). Additionally, 
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transgender individuals agreed with this crucial point that better education was needed, 
and they believed it was imperative for clinicians and all who are in contact and deal with 
transgender patients (Arora et al., 2020; Qureshi et al., 2017). It was imperative to make 
educational material available, especially to nursing staff, because it positively impacts 
clinicians' interactions (Yingling et al., 2017). 
The Veterans Health Administration (VHA) had noted an increase in transgender 
people seeking health care; because of this increase, the VHA had implemented a 
coherent national policy, which included training for all staffers, this empowered them to 
provide high-quality care to transgender veterans (Kauth et al., 2014). Providing access to 
primary care providers with education in transgender health had significant benefits and 
was among the most reliable indicators for feeling safe and seeking immediate care when 
needed and not delaying it (Kattari et al., 2019). Health care providers also displayed a 
substantial degree of confidence in the care and treatment of transgender people when 
provided educational and informational materials (Arora et al., 2020). 
Yingling et al. identified that the nurse's role in transgender access to care was 
unique and pivotal (2017). Nurses were the single largest group of clinicians and 
healthcare providers. They serve in every discipline and every department in a medical 
facility from triage to surgical. This diversity puts nurses in a position to identify and 
address the health disparities of transgender people and be able to follow their health 
needs long-term. Kauth et al. (2014) found that more transgender servicemembers sought 
health care services with more primary care staff education. Because of the unique 
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positioning nurses have, they would benefit the most from transgender health education, 
and they would provide the most return on investment in health services. Educational 
material must be made available to accomplish this goal on transgender health and enlist 
professional nursing organizations' support (Yingling et al., 2017). 
Fiduciary Barriers 
Much like the cisgender community, money plays a significant role in access to 
care and sometimes causes barriers to care. Intangibles such as the belief or fear of 
discrimination can cause transgender adults to delay care (Kattari et al., 2019); in that 
same way, finances form a tangible barrier. Gender nonconforming individuals faced the 
most significant challenges in paying for care and, because of that, were most likely to 
forego care (Gonzales et al., 2017). 
Shires and Jaffee (2015) reported that people in the transgender community who 
were 45 or older and making over $60,000 a year were indicators that an individual 
would have better access to care. Only 29.7% reported being over 50, and in the 
cisgender community, the number neared 50% (Seelman et al., 2018). Household income 
also revealed significant differences from the cisgender population; only 26.7% claimed 
an income over $50,000 and in the cisgender community, that number was 49.8% 
(Seelman et al., 2018). All transgender people of low income faced difficulties obtaining 
or being refused care; the refusal of care was highest for MtF transgender women of 




The transgender community consisted of people from all aspects of religiosity: 
some were ardent, others are not religious but spiritual, while still others professed to be 
agnostic or atheistic (Toscano, 2017). At almost every turn, transgender people were 
treated differently from the cisgender population. Schools run by those of different 
religions were not exempt from their beliefs too. 
In Christianity, one parochial school was committed to the belief that it is 
transsexuality and all forms of homosexuality, which were "not of God" and were a 
reason for expulsion (Ross & Dunkerly-Bean, 2018). This one school was not 
uncommon, as roughly 75% of middle and high school students did not feel safe because 
of their gender expression (GLSEN, 2017). 
Kanamori et al. (2019) found that on the other hand, people that believed that God 
was in control of everyone's life viewed transgender people as "the way God made them" 
and are more willing to accept them the way they are. Consistent data indicated a higher 
level of prejudice against transgender people in the cisgender population, who identified 
as being more religious in the sense that they believed themselves more literate in their 
religion and had increased attendance of services more than others (Campbell et al., 
2019). Regardless of how religious men and women saw themselves, research supported 
the perspective that women place higher human value in a transgender person than men. 




In Islam, some analyzed the Qur'an and understood the term fitna (social discord) 
and the term fasad (personal corruption) as predestined phenomena in the Muslim world. 
The second term is sometimes interpreted as the lesser evil; therefore, choosing the fasad 
(living as a transgender person) rather than causing fitna (getting married to a woman) is 
acceptable (Alipour, 2015). In Islam, the prevailing thought was that sexual activity, 
which is not limited to man-woman, was against actual Islamic teaching (Shah, 2016). An 
invitation to Islamic tolerance towards transgender people was made with Ayatollah 
Khomeini's fatwas in Iran and Sheikh Muhammad al-Tantawi in Egypt when they 
expressed their support for sex reassignment surgery by saying it was not forbidden 
(Alipour, 2017). 
In Hinduism, the transgender community was treated as equals with all others 
throughout history, and it was only after the British colonization that transgender people 
became condemned in society (Agoramoorthy & Hsu, 2015). Within recent years, a 
staunch Hindu nationalist movement had fueled a partial acceptance of the transgender 
community, but this only pertains to gender and does not apply to sexual preference (Ung 
Loh, 2018). The theme of accepting transgender people as a distinct culture was strong in 
Hindu. Shiva, the Hindu's principal deity, had one manifestation: half woman and half 
man named Ardhanari, seen in numerous temples today (Agoramoorthy and Hsu, 2015). 





The Health Belief Model (Rosenstock et al., 1988) was one of the first 
frameworks to address health behavior and is the theoretical framework used in this 
research. The model estimates that modifying variables such as age, race, economy, and 
gender impact a person's perception of severity and influenced by barriers were a 
predictor of future behavior. The health belief model was developed by four scientists, 
Irwin Rosenstock, Godfrey Hochbaum, S. Stephen Kegeles, and Howard Leventhal, who 
worked for the U.S. Public Health Service in the 1950s (Carpenter, 2010). The health 
belief model was applied frequently regarding preventative health concerns. Researchers 
used the health belief model to address people’s perceived susceptibility regarding their 
risk for disease or health problems coupled with their perceived benefits of initiating care 
to discover any influence on their willingness to engage in preventative care. Action, it 
was found, was only weakly correlated with behavior (Armitage & Conner, 2000). 
Carpenter (2010) suggested that the health belief model's theoretical constructs were not 
specific and only roughly defined. Glanz et al. (2008) explained that this limitation was a 
function of the construction of the health belief model because it did not stipulate the 
relationships of its constructs.  
According to Janz and Becker (1984), they reported evidence that barriers, 
benefits, and susceptibility were good predictors of behavior; however, they found that 
severity was not a good predictor of behavior. Carpenter (2010) similarly reported that 
benefits and barriers were strong and consistent predictors of behavior. Kok et al. (2014) 
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stated that the health belief model was an applicable theoretical framework in evaluating 
a person's self-efficacy and how their outcome expectations manipulate their behavior to 
act regarding the fear they experience related to the health situation. 
Cross-sectional data was not a proper application for selecting the health belief 
model because, over time, perceptions change, which could affect behavior, this produces 
inaccurate estimates of the relationship between the different components and the 
behavior of self-efficacy (Rosenstock, 1974). Janz and Becker (1984) presented a 
contrary perspective and suggested that some of the cross-sectional relationships would 
not be as strong, more specifically, they would become weaker. 
This research focused on transgender individual’s perceived health status and 
attempted to address if this was a significant factor in prompting an individual to engage 
in preventative care. The health belief model provided a baseline of demographic and 
psychosocial factors included in this research as the control variables and included age, 
race, sex, marital status, current health behaviors, and numerous others. Perceived 
susceptibility in this research, an individual’s perceived health was a dependent variable. 
It was analyzed along with the other dependent variable of receipt of preventative care 
and their association with the independent variable. The independent variable for the 
research effort was an individual’s gender, specifically transgender or cisgender. 
Additionally, when an individual identified as transgender, they were further evaluated as 
MtF or FtM. Upon completing this research, future research should focus on this detail, 
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whether the individual believes in the benefit of their action to seek preventative care or 
are frightened into acting. 
Literature Review Summary 
This review highlighted population access to health care, quality of care, and 
social determinants of health disparities for transgender individuals living in the U.S., as 
well as evidence gaps that exist. Because of their unique physical and mental health 
needs, encouraging the use of and access to preventative services, customized programs, 
and services for the transgender population needs to be developed and socialized 
throughout the community. These programs must include patient education and provide 
education modules to bridge the knowledge gap and foster understanding from both 
perspectives of health issues. 
The theoretical framework chosen for this research was the health belief model, 
which applied to the construct of the study. To determine if the perception of one’s health 
was a factor to action, the health belief model provided the framework to track and 
outline the steps of this research effort. 
Definitions 
Assigned gender: Natal sex (LGBTQIA, 2020). 
Cisgender: An individual whose chosen expression of sexuality aligns with their 




FtM: A biological natal female who identifies as a male individual. (Parents and 
Friends of Lesbians and Gays [PFLAG], n.d.). 
Gender: The awareness and identification of different social, psychological, and 
emotional behaviors often prejudiced by societal expectations (PFLAG, n.d.). 
Gender-Affirming Surgery (GAS): Also known as Sex Reassignment Surgery 
(SRS). The assemblage of surgeries undertaken under the direction of numerous medical 
professionals by an individual to align their chosen sexual orientation with their gender 
and not their natal biological sex (PFLAG, n.d.). 
Gender Dysphoria: The mental anguish caused by an inconsistency between a 
person’s subjective identification of gender and their biological natal sex (Bonifacio et 
al., 2019). 
Gender expression: A manner in which a person demonstrated, both visually and 
verbally within a specific culture, their gender (LGBTQIA, 2020). 
Gender Identity: A person's subjective interpretation of what their sexual 
orientation and sex are based on biological, social, psychological, and emotional factors 
(Buck, 2016). 
MtF: A biological natal male who identifies as a female (PFLAG, n.d.).  
Sexual orientation (noun) – How an individual characterizes the romantic, 
emotional, and sexual feelings they possess towards other individuals regardless of sex. 
(LGBTQIA, 2020; PFLAG, n.d.). 
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Transgender: An individual self-identification of a chosen gender which may be 
different from that of their natal sex (Buck, 2016) 
Assumptions 
Four assumptions were made during the creation and analysis of this research. 
The first assumption was that all questionnaires were answered truthfully and accurately. 
The second assumption was that the number of transgender people was measured 
accurately in the BRFSS. Understanding this population's traditional underrepresentation 
was essential and considered in the analysis portion of the study (Meerwijk & Sevelius, 
2017; D’Angelo, 2018). The third assumption was the possibility of self-reporting bias 
(Rosenman et al., 2011), which is common in research. However, self-reporting bias is 
still to be studied in the transgender population. Fourth, it was assumed that the data used 
generally avoided reporting bias even though reporting bias has been demonstrated 
within transgender survey results (McCullough et al., 2019). 
Scope and Delimitations 
The scope of this study was the transgender community and quantitative analysis 
was conducted with measurable results using the data collected from the Behavioral Risk 
Factor Surveillance System (BRFSS). The BRFSS was a telephone survey including 
more than 400,000 people yearly in the U.S. It is conducted annually by the Centers for 
Disease Control and Prevention (CDC) and addresses behavioral risks to health outcomes 
(2014). The datasets used for this project contain weighted data from the three cross-
sectional studies of 2014, 2015, 2016, 2017, and 2018. This research focused on the 
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general population of the U.S. yet included the most extensive samples of transgender 
individuals (both MtF and FtM) collected to date. It pertained to engaging different types 
of preventative health care by transgender and cisgender people based on their perceived 
health status; it measured those actions between the transgender and cisgender 
populations and the actions between MtF and FtM transgender people. This research 
focused solely on the actions that led people to pursue preventative healthcare within the 
U.S. population and any associations among transgender people and cisgender people. 
This research addressed the gap in the literature where a transgender person’s perceived 
health was analyzed to predict if it would lead a person to seek preventative care. 
This project did not distinguish between transgender people in a pretransition, 
post-transition, or declined transition status. Some transgender people elect gender-
confirming treatment, including hormonal and surgical support, but this study did not 
differentiate among them because that information was not available. 
This research is generalizable throughout the United States because the BRFSS is 
a telephonic, cross-sectional study that derives its sample from calls made on landlines 
and cellular devices to U.S. citizens from all 50 states (CDC, 2014) and the District of 
Columbia and three U.S. territories (CDC, 2014). The focus for the scope of this 
investigation was to address if an individual’s self-perception of their health was an 
influencing factor for them to pursue preventative care and identify associations between 
transgender and the cisgender population regarding perceived health and receipt of 
preventative care, controlled for demographics. The research.  
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Significance and Conclusions 
Significance of the Study 
The significance of this study was that it addresses a gap in the literature and that 
it offers functional knowledge about the perceptions of the current health status of 
individuals in the transgender community and their engagement with pursuing 
appropriate preventative care. Several studies have used some of the data used for this 
research to examine health outcomes by assessing barriers to care. However, no studies 
were located in the literature investigating individuals who engaged in preventative care 
by assessing their health perceptions. 
This project supports the mission of positive social change by explaining the 
determinants that impact different types of preventative care. The goal was to better 
understand the factors that lead people in the transgender community to seek preventative 
medical care. Findings may assist policymakers, epidemiologists, community planning 
groups, and other stakeholders in determining at-risk subpopulations. 
Significance to Practice 
Compared to the cisgender population, the transgender community 
disproportionately lacks obtaining preventative care (Safer et al., 2016). In several cases, 
the barriers to care are understood, while an individual’s subjective perception of their 
current health status and their willingness to seek preventative care was not studied. The 
transgender community suffers from higher rates of sexually transmitted diseases 
(including HIV/AIDS), depression, self-harm, domestic abuse, and many other health 
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maladies (Dinno, 2017). In pursuing this research effort, the community achieved a better 
understanding of an unknown factor, which could be essential in increasing access to 
preventative health care and thus the number of transgender people seeking and receiving 
preventative health care. 
Significance to Social Change 
This project supports positive social change in how healthcare providers support 
transgender people with timely access to care. Its findings support the ODPHP strategy of 
identifying and clarifying health needs by focusing on transgender people’s perceptions 
about subscribing to preventative care (2019). Finally, this project may improve 
understanding of the determinants that impact different types of preventative care to 
better understand the factors that lead people in the transgender community to seek 
preventative medical care. 
Summary 
This section included several components. The first part was a look at the nature 
of the study. This study was a quantitative cross-sectional study investigation that 
analyzed data from adult participants, aged 18 and older, in a national study. The national 
study was the BRFSS and the data included the years 2014 through 2018. 
The second component included the Research Questions and hypothesis 
associated with each Research Question. There are four research questions that are tooled 
to investigate the differences between transgender and cisgender people and the 
differences between MtF and FtM individuals in the transgender subgroup. The 
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differences being investigated include perceived health and if an individual’s perceived 
health is an indicator of obtaining medical care. 
Thirdly, a complete review of the literature associated with transgender people 
was conducted. In this review, an investigation of the available research that continues to 
accumulate related to healthcare barriers for the transgender population was conducted. 
In this section, numerous potential influencers on preventative care in the transgender 
population were discussed. Additionally, the health belief model's application as the 
theoretical framework to the research was explained and shown how it guides this 
research effort. 
The literature review highlighted the numerous variables relevant to health 
outcomes and preventative care in the transgender community; however, a gap in the 
literature existed when investigating a transgender person’s perceived health status and 
that relationship to that individual either implementing or not implementing some 
preventative care. To date, research does not address if a transgender man who has 
completed gender reassignment surgery believed, for example, that a mammography is 
essential for health. This study attempted to answer these types of questions related to 
preventative medicine use by the transgender community. 
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Section 2: Research Design and Data Collection 
The methodology section included several subheadings (a) research design and 
rationale, (b) data collection techniques, and (c) the methodology used in this research 
project. These sections included information concerning the sample population and 
analytical requirements; they addressed inclusion and exclusion parameters in the sample 
and the sampling population. Additionally, this section included an a priori power 
analysis to assist in detecting type II errors. This section also included the sample and 
sampling techniques, data collection methods, and the instrumentation and 
operationalization of variables. The chosen data analysis techniques used in this study 
were discussed. Next, threats to internal validity and external validity were analyzed. 
Finally, ethical considerations were also presented, followed by a summary. 
Research Design and Rationale 
The purpose of this study was to investigate if there were differences between 
members of the transgender and non-transgender population regarding perceived health 
and the receipt of preventative care when controlled for demographics. Also, potential 
differences in perceived health and the receipt of preventative care investigated by 
transgender type when controlled for demographic variables. This quantitative study used 
cross-sectional secondary data (BRFSS, 2014-2018) from the general population of 
adults in the U.S. It was the most extensive annual cross-sectional data collection of the 
U.S. population that included the variable of gender identity. The cross-sectional design 
was chosen because it allowed (a) for the inclusion of the BRFSS data from several years, 
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which enabled extensive analysis of the transgender population and cisgender population 
and (b) for the calculation of the odds ratio, which quantifies the strength of the 
association between the independent and dependent variables (Szumilas, 2010). 
Methodology 
Population 
The BRFSS data were collected annually from 2014-2018 and included an annual 
sample of over 435,000 each year. The BFRSS used a health-related telephone survey 
where researchers called both landlines and cell phones. The survey included core 
questions with optional modules and an opportunity for questions to be added by the 
state. The sampling population was the U.S. and several of her territories and her 
possessions. 
Sampling and Sampling Procedures 
Researchers collected data using the instrumentation of their BRFSS annual 
questionnaire (About BRFSS, 2014). Researchers then used the BRFSSS Questionnaire 
(2014-2018) at the CDC during telephone interviews in a longstanding data collection 
policy established in the mid-1980s (BRFSS - Survey Data, 2019). Researchers collect 
data, interpret the data, and utilize it to improve public health beginning in 1984 at the 
inception of the project (BRFSS - Survey Data, 2019). The CDC staff stored the data in 
an online archive by year separated by calendar year. The data were publicly accessible 
and open for use by the public. The administrators of the BRFSS obtain informed consent 
during the survey either on landline or cell phone. The data were weighted, anonymized, 
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and publicly available at the BRFSS Survey Data and Documentation website (BRFSS - 
Survey Data, 2019). CDC staff used the BRFSS questionnaire to collect data about U.S. 
residents’ concerning their health-related risk behaviors, chronic health conditions, and 
what preventative services they used (About BRFSS, 2014). 
The annual sample size for the BRFSS consists of over 435,000 U.S. adults who 
participated in the survey each calendar year. Cicero et al. (2020) agreed that the 
questionnaire was the most comprehensive data collection tool to date and a good start. 
The questions pertaining to transgender people may not be weighted precisely correct and 
did not fully reflect the accuracy needed for correct health interventions. Rolle-Lake 
(2020) suggested that low response rates, needed adaptions to change in means of 
communication, and reaching a multi-language diverse population were all limiting 
factors to the survey. 
Instrumentation and Operationalization of Constructs  
Instrumentation 
The instrument for data collection was the BRFSS survey administered 
telephonically by researchers at the CDC. Data were captured by the researchers and 
input when they received answers from the individuals they interviewed. The survey was 
conducted on either a landline or a cell phone with adults, 18 years old or higher, in the 
U.S. and several of her territories. 
Operationalization of Constructs 
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This study leverages surveys covering the period of 2014 through 2018. Each 
survey was constructed similarly. There were three sections for these surveys (a) the core 
component, inclusive are the fixed core, rotating core, and emerging core (b) optional 
modules, and (c) state-added questions (About BRFSS, 2014).  
The fixed core containing standardized questions asked by all states included 
questions on demographics and questions on current health behaviors, such as tobacco 
use and seatbelt use (About BRFSS, 2014). The rotating core was comprised of two 
unique sets of questions; each group was presented in alternating years in every state and 
territory, addressing different topics. In years rotating core topics go unused, they were 
recommended as optional modules (About BRFSS, 2014). The emerging core section 
included up to five questions that were added to the fixed and rotating cores. Emerging 
core questions usually addressed “late-breaking” issues. This group of questions were 
included in the core section for one year and were analyzed to identify potential value in 
future surveys. 
Data Accessibility and Permissions 
The datasets used in this research project were publicly available and easily 
accessible to anyone at the Centers for Disease Control and Prevention website (BRFSS - 
Survey Data, 2019). There were no special permissions or requirements for accessing the 
BRFSS data. CDC officials managed the data by calendar year, and each completed core 





The statistical significance level, or alpha, for this research was .05. A confidence 
level of 95% was used with a confidence interval of +/- 3% as a measure of reliability. 
When a true null hypothesis is rejected, it is a Type I error, with a probability symbolized 
by α, but when there is a difference between the means and the null hypothesis is 
accepted, then a type II error, symbolized by β, has been committed (Hoffman, 2019). 
Also, calculating the optimal sample size in research was essential because it spoke 
directly to the study's power calculations (Melnyk & Morrison-Beedy, 2019). A larger 
sample size leads to greater statistical power. 
A statistical test's power is represented as 1-β, where β represents the size of a 
type II error (Hoffman, 2019). Additionally, Hoffman (2019) indicated that the power test 
enabled a researcher to determine if the null hypothesis was rejected correctly. 
The χ² sample size was calculated on the G*power version 3.1.9.4 to obtain the 
sample size for this study. The table below included the results of the sample size 
calculation. The calculated sample size for this study was 145, when an equal sample size 
for each group is used, the total sample size from the population is 290. 
Table 1 





Research Question and Hypotheses 
RQ1–Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in the 
U.S.? 
Ho1: There is no significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in 
the U.S. 
Ha1: There is a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in 
the U.S. 
Independent variable: being transgender (yes/no). 
Dependent variables: perceived health and receipt of preventative care. 
Control variables: age, race/ethnicity, income 
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RQ2–Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and female-to-
male (FtM) transgender adults? 
Ho2: There is no significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and 
female-to-male (FtM) transgender adults. 
Ha2: There is a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and 
female-to-male (FtM) transgender adults. 
Independent variable: transgender type [male-to-female (MtF)/female-to-male 
(FtM)] 
Dependent variables: perceived health and receipt of preventative care 
Control variables: age, race/ethnicity, income 
RQ3-Quantitative: Are there significant differences between the MtF and FtM 
transgender adults in the frequency of medical treatments pursued by those with 
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substantial chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS)? 
Ho3: There are no significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial 
chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS). 
Ha3: There are significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial 
chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS). 
Independent variable: transgender type [male-to-female (MtF)/female-to-male 
(FtM)] 
Dependent variable: frequency of medical treatments. 
Control variables: age, race/ethnicity, income 
RQ4- Quantitative: In the adult population, is there a significant difference 
regarding perceived satisfaction of care and the number of medical appointments 
conducted between MtF transgender, the FtM transgender, and the non-transgender 
communities? 
Ho4: There is no significant difference regarding perceived satisfaction of care 
and the number of medical appointments conducted between MtF transgender, the 
FtM transgender, and the non-transgender communities. 
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Ha4: There is a significant difference regarding perceived satisfaction of care and 
the number of medical appointments conducted between MtF transgender, the 
FtM transgender, and the non-transgender communities. 
Independent variable: transgender status (MtF transgender, the FtM transgender, 
non-transgender) 
Dependent variables: perceived satisfaction of care and the number of medical 
appointments. 
Control variables: age, race/ethnicity, income 
Operationalization of Var iables 
The variables explored in the study were numerical variables. The independent 
variable was gender identification (categorical/nominal variable). The dependent 
variable's levels of measurement were nominal, and each variable contained multiple 
groups. Table 2 aligned research questions and variables, while Table 3 showed the 
variables and indicated each variable's definition, measurement level, and attributes.  
Table 2 
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4 – No, prediabetes or borderline 
diabetes 
7 – Don’t know/Not sure 




Pearson’s Chi-square test for independent samples for categorical variables for all RQs. 
Pearson’s chi-square test was administered to analyze the difference in proportions 
between two independent samples and test whether there was an association between the 
variables. Second, multivariable analysis (binomial logistic regression [BLR]) was 
conducted per RQ also to assess the effect of confounders of race/ethnicity, age, 
education, and income. Each dependent variable per RQ was recoded into a binary 
categorical variable to accomplish this analysis. The selected statistical significance level 
was a p-value < 0.05. 
Threats to Validity 
This section focused on things that can affect the validity, both internal and 
external. Cicero et al. (2020) noted that in the 2015 BRFSS methodology, interviewers 
assessed an individual’s sex based on that individual’s vocal timbre. This subjective 
assumption created a misclassification bias and is essential because 74% of MtF and 66% 
of FtM individuals had a conflict between their stated gender identity and what the 
interviewers recorded. Subsequent years questionnaires specifically direct the 
interviewers in gaining sex and gender identification information from the individual 
surveyed and not have that information come from the interviewed. 
External Validity 
Threats to external validity included selection bias; this was from improper or 
lack of randomization, it led to a sample that did not appropriately represent the 
population. The dataset only contained people called on a landline or a cell phone, 
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meaning that the study was generalizable to this greater population. The U.S. had a cell 
phone saturation at 129 subscriptions per 100 people and 34 landlines per 100 people, 
meaning there are more telephones than people (The World Factbook, 2018). 
Internal Validity 
Several factors affect internal validity in a study. Lack of statistical power was an 
essential threat to statistical conclusion validity, a type of internal validity, leading a 
researcher to draw inaccurate conclusions from the data (Creswell, 2009). Another threat 
to the internal validity of a study was events that were external to the experiment; these 
factors fell under the heading of history. We must consider history because various events 
may influence the study's many variables differently (Melnyk & Morrison-Beedy, 2019). 
Other threats to internal validity include instrumentation, maturation, regression, 
selection, and testing (Melnyk & Morrison-Beedy, 2019). Because this study includes 
cross-sectional data from the BRFSS, there was no issue of maturation or attrition. The 
instrumentation from the CDC was a reliable tool under constant scrutiny and 
improvement. Only the validity question is related to the 2015 BRFSS methodology 
previously mentioned where interviewers assumed an individual’s sex based on voice 
recognition alone. 
Ethical Procedures 
The Walden University IRB had defined specific processes for students to follow 
when considering any data for inclusion in a project (Research ethics and compliance, 
n.d.). This process is intended to closely monitor for inappropriate or inadvertent use of 
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human subject data. The U.S. Federal Government had requirements and restrictions 
outlined in the U.S. Code of Federal Regulations (CFR). It was explicit what compliance 
was needed for researchers when they used data related to human subjects. The U.S. law 
categorized the use of BRFSS data as public data because these are de-identified data. 
Prior to the conduction of the study, Walden IRB approval was applied for and received 
(Approval No. 08-05-20-0540538). 
Summary 
This section outlined the research design and rationale and the data collection 
techniques and methodology used in this research project. The methodology section 
included material characterizing the population, samples, and analytics. This section 
additionally included the data collection methods and the instrumentation and 
operationalization of variables alone with statistical tests used with an overview of the 
population. Next, threats to internal validity and external validity were analyzed. Finally, 
ethical considerations associated with this effort were addressed, followed by a summary. 
Section 3 included the findings from this research effort. 
64 
 
Section 3: Presentation of the Results and Findings 
The purpose of this cross-sectional study was to explore potential differences 
between the transgender and the cisgender population regarding perceived health and 
receipt of preventative care after controlling for demographics.  
For each research question, descriptive statistics were examined first to 
investigate the trends of the sample. Inferential statistics were completed in two phases. 
First, bivariate analyses were explored using Pearson’s chi-square test for association 
between categorical variables. The chi-square test was also used to analyze the difference 
in proportions between two independent samples; it tested whether there was an 
association between the variables. Second, multivariable analysis (binomial logistic 
regression) was conducted to assess the effect of potentially confounding variables: 
race/ethnicity, age, education, and income. Each dependent variable was recoded into a 
binary categorical variable to achieve the logistic regression. The selected statistical 
significance level was p < 0.05. 
Research Question 
RQ1–Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 




Ho1: There is no significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in 
the U.S. 
Ha1: There is a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in 
the U.S. 
RQ2–Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and female-to-
male (FtM) transgender adults? 
Ho2: There is no significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and 
female-to-male (FtM) transgender adults. 
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Ha2: There is a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and 
female-to-male (FtM) transgender adults. 
RQ3-Quantitative: Are there significant differences between the MtF and FtM 
transgender adults in the frequency of medical treatments pursued by those with 
substantial chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS)? 
Ho3: There are no significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial 
chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS). 
Ha3: There are significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial 
chronic medical issues (such as asthma, stroke, heart attack, diabetes, cancer, 
HIV/AIDS). 
RQ4- Quantitative: In the adult population, is there a significant difference 
regarding perceived satisfaction of care and the number of medical appointments 




Ho4: There is no significant difference regarding perceived satisfaction of care 
and the number of medical appointments conducted between MtF transgender, the 
FtM transgender, and the non-transgender communities. 
Ha4: There is a significant difference regarding perceived satisfaction of care and 
the number of medical appointments conducted between MtF transgender, the 
FtM transgender, and the non-transgender communities. 
Time Frame of Data Collection and Response Rates 
Each year, from 2014-2018, a survey was conducted by the CDC—the BRFSS. 
People in the 50 states, the District of Columbia, and the territories were randomly 
telephoned about their health-related behavior and chronic diseases. Sampling involved 
both land and cellular calls to adults who were 18 or older. This study used these annual 
data. 
Discrepancies in the Dataset 
Duplicate variables  
Two variables (INCOMG, INCOME2) for income status were identified for 
inclusion; however, because they were closely related, one was removed (INCOME2), so 
only one income-related demographic was used in this research project. INCOMG is the 




 The BRFSS data were incomplete, and certain limitations were identified. In 
2017, 12 dependent variables used in this project were not collected. In 2015 three 







For five variables, which included fourteen instances, data were renamed to the 
2018 codebook category. This renaming allowed for the consistent use of data for all five 
years of the BFRSS. The data were characterized the same in each of the different 
codebooks; it was only the category name that was changed. 
Table 7 




Recoded RQ1 RQ2 RQ3 RQ4 
Yes, MtF 1 1 1 1 
Yes, FtM 1 2 2 2 
Yes, Non-
conforming 
1 - - - 
Cisgender 0 - - 0 
 
PHYSHLTH was converted from a string value to a categorical data item 











Variable Name Recoded  Code 
CHECKUP1 Within the past year  1 
Within the past 2 years  1 
Within the past 3 years  0 
Within the past 5 years  0 
5 or more years ago  0 
 
 







Data were used starting with 2014, the first-year transgender information was 
recorded, up to and including 2018, which was the latest data available. The total of 
interviews from these five years was 2,278,508.  
Table 18 




subgroup of transgender, MtF participants (n = 1,874, 45.75%) represented nearly half of 
the sample with FtM transgender (n = 1,340, 32.71%) and gender-non-conforming with 
the least number of participants (n = 882, 21.53%). 
 
Table 20 





Distribution of Participant’s by Gender in Research Question 1 
 
In Research Question 2, 332 individuals surveyed in BRFSS identified a specific 
transgender status and had all variable data needed for this analysis included in their 
profile. From that sample, 194 adults (58.43%) were identified as MtF transgender, while 






F ig u r e 2  
D istr ib u tion  of  P a r tic ip a n t’ s b y  G en d er  in  R esea r ch  Q u estion  2 
 
I n R esearch Q uestion 3, 513 indiv iduals surv ey ed in B R F S S  identi f ied a spec i f i c  
transg ender status and had al l  v ariable data needed for thi s anal y si s inc luded in thei r 
prof i le. F rom  that sam ple, 311 adul ts (60.62% ) w ere identi f ied as M tF  transg ender, w hi le 
202 adul ts (39.38% ) w ere recorded as F tM  transg ender as show n in F i g ure 3. 
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Figure 3  
Distribution of Participant’s by Gender in Research Question 3 
 
In Research Question 4, 174,591 individuals surveyed in BRFSS identified a 
specific transgender status (MtF or FtM) or were listed as cisgender and had all variable 
data needed for this analysis included in their profile. From that sample, 390 adults 
(0.22%) were identified as MtF transgender, while 263 adults (0.15%) were recorded as 






Figure 4  
Distribution of Participant’s by Gender in Research Question 4 
 
 
Representativeness of the Sample 
To maintain representativeness, the CDC included cell phone and landline 
participants in their surveys because they represented different demographics of people. 
(BRFSS, n.d.) Furthermore, the change from a post-stratification weighting methodology 
to a raking weighting method in BRFSS happened in 2014. This change accounted for the 
continually changing proportions of known demographic characteristics (i.e., age, race, 
income, ethnicity, sex, telephone source, and region) and allowed for the inclusion or 
expansion of analysis of other characteristics (marital status, education level, and 





It was reported that the transgender population had been traditionally 
underrepresented; Crissman et al. (2017) surmised that transgender people comprise 
0.53% (95% confidence interval [CI] = 0.46, 0.61) of the U.S. population. Flores et al. 
(2016) estimated using the BRFSS data from 2016 that the transgender adult population 
was calculated at 0.6% of the adult population. Demographics of the group specific to 
age, socioeconomic status, marital status, education level, and healthcare access were all 
generalizable to nationally reported data for this population. 
Study Results 
The following subsections included statistical assumptions and results of the four 
research questions as well as explorative analysis. 
Statistical Assumptions 
Data for each RQ were analyzed using crosstabs and Pearson’s chi-square test. 
The five assumptions of a chi-square test included (a) individual level data, (b) mutually 
exclusive categories, (c) independence, (d) nominal or ordinal categories, and (e) 
variables are dichotomous and categorical and there should be five or more cases in 80% 
of the cells (McHugh, 2013). All the chi-square test assumptions were met because the 
groups are nominal or ordinal, mutually exclusive, independent, and had cell counts with 
more than five individuals. 
Five assumptions existed for Binomial Logistic Regression (BLR), which were 
(a) dependent variable must be binary, (b) independents observations, (c) little or no 
multicollinearity in the independent variable, (d) linearity of the independent variable, 
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and (e) a large sample size (minimum of 500) (Statistic Solutions, 2019). All the 
necessary assumptions for this methodology were met because the dependent variables 
are dichotomous, cases are independent with no multicollinearity and for RQ1, n = 
96,718; RQ2, n = 332; RQ3, n = 513. 
Three assumptions existed for exact test for goodness of fit for the Hosmer 
Lemeshow test, which were (a) variable must be binary, (b) each of the observations were 
independent, and (c) groups of the categorical variable must be mutually exclusive 
(Exact, 2020). All the exact test for goodness of fit assumptions were met because the 
variables are binary, observations were independent, and all categorical variables were 
mutually exclusive. 
Research Question 1 
RQ1–Quantitative: Is there a significant difference regarding perceived health and 
receipt of preventative care (such as mammograms, PAP test, influenza vaccination, 
pneumonia vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender and non-transgender adults in the 
U.S.? 
Univariate Analysis 
Descriptive Statistics. The majority of this sample was comprised of White only, non-
Hispanic participants (n = 75,451, 78.0%). The least in representation by percentage are 
Native Hawaiian or other Pacific Islander (n = 422) and Other Race only, non-Hispanic 
(n = 367). Both were 0.4%. 
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Figure 5  
Ethnicity by Percent 
 
Age was more heavily distributed towards 60–64-year-olds (n = 12,159, 12.6%), 
55–59-year-olds (n = 11,454, 11.8%), and 65–69-year-olds (n = 10,841, 11.2%). 
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Figure 6  
Sample by Age 
 
Income was disproportionately distributed among participants. The greatest 
distribution was in the highest income bracket of $75,000 or more (n = 27,007, 27.9%), 
descending in number - by income level to the lowest income bracket (Less than $10,000: 
n = 5,744, 5.9%).  
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Figure 7  
Sample by Income Level 
 
Natal sex was more distributed towards male participants (59,224, 61.2%). 
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Figure 8  
Sample by Natal Sex 
 
Finally, FIPS Code (representing locality) characterized significant participation 
from New York (12,285, 12.7%) and Virginia (10,245, 10.6%). The least participation 
was from North Carolina (69, 0.1%), Montana (104, 0.1%), and Tennessee (91, 0.1%). 
All other locations represented between 0.2% (Kansas) and 5.1% (Minnesota). 
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Figure 9  
Sample by Location 
 
Nominal level frequencies and coding of the demographic variables were 
presented in Table 20. 
 
Table 21 




Reported age in five-
year age categories 
calculated variable 






higher the strength of the association. Based on this effect size analysis, the only 
significant chi-square value result of influenza vaccination was a weak association 
described by Cohen (1988). 
Table 22 





Post Hoc Analysis. A post hoc power analysis was conducted for the chi-square test 
results using the G*Power software package. A sample size of 96,718 was used. The 
recommended effect sizes used for this assessment was medium (r = .3) (Cohen, 1988). 
The alpha level used for this analysis was p < .05. The post hoc analyses revealed that 
this study's statistical power was 83.63% for detecting a medium effect, whereas the 
power exceeded .99 to detect a moderate to large effect size. Thus, there was more than 
adequate power (i.e., power > .80) at the medium effect size level. 
 
Table 23 




identify as transgender when compared to White only, non-Hispanic [OR = [3.616], 95% 
CI (1.413, 9.252)]. 
Table 24 
Binomial Logistic Regression for Influenza Vaccination with Predictors Locality, Sex, 






Analysis of the chi-square test results showed the association of the cisgender 
group and influenza vaccination status as statistically significant. In the logistic 
regression, influenza status was shown not to be significant when analyzed within the 
demographics. However, the regression model also indicated that one of the demographic 
groups in the race variable (Other race only, non-Hispanic) was statistically significant. 
This finding, however, was not in the scope of the research question, so therefore the null 
hypothesis should be rejected. 
Research Question 2 
Is there a significant difference regarding perceived health and receipt of 
preventative care (such as mammograms, PAP test, influenza vaccination, pneumonia 
vaccination, tetanus vaccination, human papilloma vaccination, 
sigmoidoscopy/colonoscopy) between transgender male-to-female (MtF) and female-to-
male (FtM) transgender adults? 
Univariate Analysis 
Descriptive Statistics. Nearly seven out of ten records in this sample consisted of White 
only, non-Hispanic participants (n = 230, 69.9%). 
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Figure 10  
Sample by Race 
 
Age was more heavily distributed towards older adults, with more respondents 
aged 55 to 59-years old (n = 49, 14.9%) then 50–54-year-olds (n = 42, 12.8%) and 60–
64-year-olds (n = 40, 12.2%). 
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Figure 11  
Sample by Age Group 
 
Income brackets were distributed relatively equally. There was a similar number 
of people in the highest income bracket of $75,000 or more (n = 52, 15.8%) as in the 
lower-income bracket of $15,000 to less than $20,000: (n = 52, 15.8%). Otherwise, the 
sample was focused in the remaining lower income categories of less than $10,000: (n = 
45, 13.7%) and $20,000 to less than $25,000 (n = 44, 13.4%). 
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Figure 12  
Sample by Income Level 
 
 
Natal sex was nearly evenly distributed with seven more male participants (n = 
168, 51.1%) than female participants (n = 161, 48.9%). 
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Figure 13  
Sample by Natal Sex 
 
Finally, FIPS Code (representing locality), represented significant participation 
from New York (n = 56, 17.0%) and Virginia (n = 50, 15.2%). The least frequency was 
from Florida, Kansas, Maryland, North Carolina, and Tennessee, all providing one 
participant per state (n = 1, 0.3%).  
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Figure 14  
Sample by Location 
 
Nominal level frequencies and percentages of the demographic variables were 
presented in Table25. 
 
Table 26 







Age 45 to 49 25 
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result of pneumonia vaccination was with MtF and was a weak association as described 
by Cohen (1988). 
Table 27 
Research Question 2 Combined Chi-Square Table 
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Post Hoc Analysis. A post hoc power analysis was conducted for the chi-square test 
results using the G*Power software package. A sample size of 332 was used. The 
recommended effect sizes used for this assessment was medium (r = .3) (Cohen, 1988). 
The alpha level used for this analysis was p < .05. The post hoc analyses revealed that 
this study's statistical power was 99.98% for detecting a medium effect, whereas the 
power exceeded .99 to detect a moderate to large effect size. Thus, there was more than 
adequate power (i.e., power > .80) at the medium effect size level. 
Table 28 













.000 .000 . 
Georgia .550 1.587 .120 1 .729 1.734 .077 38.870 
Hawaii 1.421 1.552 .838 1 .360 4.141 .198 86.727 




1.770 .343 1 .558 .355 .011 11.391 
Indiana .419 1.859 .051 1 .822 1.520 .040 58.125 











Kentucky 1.305 1.503 .754 1 .385 3.686 .194 70.071 









.000 .000 . 
Massachusett
s 
2.918 1.814 2.588 1 .108 18.512 .529 647.98
2 






.000 1 .999 .000 .000 . 
Missouri 2.617 1.552 2.844 1 .092 13.692 .654 286.51
7 
Nevada .913 1.836 .247 1 .619 2.491 .068 90.948 










.000 .000 . 










.000 1 .999 .000 .000 . 
South 
Carolina 








.000 .000 . 
Texas 1.830 1.475 1.538 1 .215 6.234 .346 112.38
9 
Vermont 1.527 1.503 1.032 1 .310 4.603 .242 87.573 
Virginia .545 1.391 .153 1 .695 1.724 .113 26.330 
Washington 1.444 1.491 .938 1 .333 4.239 .228 78.744 
West 
Virginia 
-.447 1.617 .076 1 .782 .639 .027 15.212 
Wisconsin -.254 1.954 .017 1 .897 .776 .017 35.725 
Guam 1.608 1.914 .706 1 .401 4.992 .117 212.50
2 
Male 2.433 .325 55.97
8 
1 .000 11.398 6.025 21.561 
Income .004 .063 .003 1 .956 1.004 .886 1.136 




5.318 7 .621 
   
Black only, 
non-Hispanic 





-.650 1.019 .407 1 .524 .522 .071 3.846 
Asian only, 
non-Hispanic 













-.241 1.943 .015 1 .901 .786 .017 35.396 
Multiracial, 
non-Hispanic 
.369 .722 .261 1 .609 1.446 .351 5.950 
Hispanic -.678 .596 1.294 1 .255 .508 .158 1.633 
Pneumonia 
Vaccine 





1 .000 .003 
  
a. Variable(s) entered on step 1: FIPS Code, Sex at birth, Income Level, Reported age in 
five-year age categories calculated variable, Race/Ethnicity, Pneumonia Vaccine. 
 
Goodness of Fit. The Hosmer and Lemeshow goodness of fit test was not significant (p 
> .05), indicating the model is correctly fitted although it had a relatively poor predictive 
ability (Nagelkerke R2 = .429). 
 
Table 30 
Hosmer and Lemeshow Test 
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Research Question 3 
Are there significant differences between the MtF and FtM transgender adults in 
the frequency of medical treatments pursued by those with substantial chronic medical 
issues (such as asthma, stroke, heart attack, diabetes, cancer, HIV/AIDS)? 
Univariate Analysis 
Descriptive Statistics. Most of this sample consisted of White only, non-Hispanic 
participants (n = 399, 77.8%). 
Figure 15  
Sample by Race 
 
Participants in the age range from 50-69-years-old were most frequent (n = 264, 
51.46%) Specific categories with the most participants were all within the 
aforementioned age range and included 60–64-year-olds (n = 72, 14.0%) and 55-59-year-
olds (n = 68, 13.3%). 
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Figure 16  
Sample by Age 
 
Income increased by category such that those who made the least (less than 
$10,000) were the least represented (n = 38, 7.4%). The distribution of participants was 
heaviest in the category of $75,000 or more (n = 96, 18.7%). 
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Figure 17  
Sample by Income Level 
 




F igure 18  
Sample by Natal Sex 
 
Finally, FIPS Code (representing locality) showed the greatest participation from 
Minnesota (102, 19.9%). States with the least participation had only a single participant 
per location: Illinois, Missouri, North Carolina, Rhode Island, South Carolina, Texas, and 




Figure 19  




Frequency Table for Demographic Variables in Research Question 3 
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Nominal level frequencies and percentages of the demographic variables were 
presented in Table 30. 
Statistical Analysis 
Chi-Square Analysis. The results of the chi-square analysis revealed a significant 
association between the FtM transgender group and three variables: arthritis, depressive 
disorder, and diabetes. FtM people experienced higher percentages with all three 
variables when compared to MtF people, arthritis is recorded at FtM (43.1%) more than 
MtF (26.2%), depressive disorder is FtM (27.7%) and MtF (18.0%), finally diabetes is 
FtM (21.3%) and MtF (14.5%). These three relationships all reached statistical 
significance (p < .05); arthritis χ2 (1, N = 513) = 11.349, p = .001, depressive disorder χ2 







(1, N = 513) = 6.774, p = .009, and diabetes χ2 (1, N = 513) = 4.005, p = .045. There was 
a statistically significant association between the FtM transgender group and the three 
variables mentioned therefore the null hypothesis was rejected. No other statistically 
significant associations were identified. 
Cramer’s V value for arthritis was statistically significant (Cramer’s V = .149, p < 
.001). It indicated a small effect of the association of the FtM group and arthritis. This 
value was close to 0 and more than .10 but less than .30. Cramer’s V value for depressive 
disorder was significant (Cramer’s V = .115, p < .009), and it indicated a small effect of 
the association of the FtM group and depressive disorder. Cramer’s V value for diabetes 
was also significant (Cramer’s V = .088, p < .045) and indicated a trivial effect (< .10) of 
the association of the FtM group and diabetes. 
 
Table 32 











Post Hoc Analysis. A post hoc power analysis was conducted for the chi-square test 
results using the G*Power software package. A sample size of 513 was used. The 
recommended effect sizes used for this assessment was medium (r = .3) (Cohen, 1988). 
The alpha level used for this analysis was p < .05. The post hoc analyses revealed that 




















599433090.837 .000 . 






.000 1 .999 .000 .000 . 
Kentucky .566 .999 .321 1 .571 1.761 .249 12.47
2 
Louisiana -.044 1.037 .002 1 .967 .957 .125 7.314 
Maryland -.272 1.025 .070 1 .791 .762 .102 5.686 


















Montana .254 1.253 .041 1 .839 1.289 .111 15.01
7 
Nevada -.075 1.275 .003 1 .953 .927 .076 11.29
4 










.000 .000 . 
Ohio .226 1.033 .048 1 .827 1.254 .166 9.495 
Pennsylvani
a 
































Vermont -.635 1.125 .318 1 .573 .530 .058 4.811 
Virginia .087 1.019 .007 1 .932 1.090 .148 8.032 




1.335 1.712 .608 1 .436 3.800 .133 108.9
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527810030.328 .000 . 
Natal Sex 1.896 .224 71.37
6 
1 .000 6.659 4.289 10.33
8 
Income -.046 .053 .772 1 .380 .955 .861 1.059 





7.622 6 .267 


























1.396 1.026 1.852 1 .174 4.039 .541 30.16
8 
Hispanic .568 .478 1.409 1 .235 1.764 .691 4.504 
Ever told 
you have a 
depressive 
disorder 
-.306 .274 1.247 1 .264 .736 .430 1.260 
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Constant -.846 1.105 .586 1 .444 .429   
a. Variable(s) entered on step 1: FIPS Code, Sex at birth, Income Level, Reported age in 




BLR for Arthritis with Predictors Locality, Sex, Income, Age, and Race 
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Montana .299 1.284 .054 1 .816 1.348 .109 16.70
4 
Nevada -.061 1.300 .002 1 .962 .941 .074 12.03
2 










.000 .000 . 


































Vermont -.565 1.146 .243 1 .622 .568 .060 5.366 
Virginia .158 1.044 .023 1 .880 1.171 .151 9.059 




1.028 1.734 .351 1 .553 2.794 .093 83.53
0 







705332905.594 .000 . 
Natal Sex 1.870 .226 68.72
2 
1 .000 6.490 4.170 10.09
8 
Income -.052 .051 1.017 1 .313 .950 .859 1.050 





7.844 6 .250 




























1.338 1.042 1.649 1 .199 3.811 .495 29.37
2 











-.350 .237 2.181 1 .140 .705 .443 1.121 
Constant -.659 1.142 .333 1 .564 .517   
a. Variable(s) entered on step 1: FIPS Code, Sex at birth, Income Level, Reported age in 
five-year age categories calculated variable, Race/Ethnicity, Ever told you have some 

















Step 4.565 3 .207 
Block 4.565 3 .207 
Model 149.604 41 .000 
 
Goodness of Fit. The Hosmer and Lemeshow goodness of fit test was not significant (p 
> .05), indicating the model was correctly fitted although it had a relatively poor 
predictive ability (Nagelkerke R2 = .349). 
Table 38 
Hosmer and Lemeshow Test 
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Descriptive Statistics. This sample was predominately White only, non-Hispanic 
participants (n = 143154, 82.0%). The Native Hawaiian or other Pacific Islander group 
was least represented (n = 378, 0.2%). 
Figure 20  
Sample by Race 
 
Age was concentrated between the thirteen options in the 50 to 69-year-old 
groups (n = 78,146, 44.76%). Individually, the 60–64-year-olds (n = 20,981, 12.0%) 





Figure 21  
Sample by Age Group 
 
Income was disproportionately distributed among participants, with the greatest 
numbers in the highest income bracket $75,000 or more (n = 55,525, 31.8%) and 
descending in number, by income level to the lowest income bracket Less than $10,000: 
(n = 7,504, 4.3%).  
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Figure 22  
Sample by Income Level 
 
 
Natal sex was distributed towards female participants (n = 98,719, 56.5%) while 
natal males comprised 43.5% (n = 75872) of the sample.  
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Figure 23  
Sample by Natal Sex 
 
Finally, FIPS Code (representing locality) showed significant participation from 
Minnesota (n = 26,692, 15.3%). The least participation came from Guam (n = 148, 
0.1%). The States with the least participants in this sample came first from North 
Carolina (0.2%, n = 420) then a group consisting of Illinois (n = 549), Mississippi (n = 
542), Missouri (n = 577), Oklahoma (n = 556), Rhode Island (n = 593), Tennessee (n = 
477), and West Virginia (n = 544) all at 0.3%. 
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Figure 24  
Sample by Location 
 
Nominal level frequencies and percentages of the demographic variables were 
presented in Table 36. 
Table 39 











Post Hoc Analysis. A post hoc power analysis was conducted for the chi-square test 
results using the G*Power software package. A sample size of 174,591 was used. The 
recommended effect sizes used for this assessment was medium (r = .3) (Cohen, 1988). 
The alpha level used for this analysis was p < .05. The post hoc analyses revealed that 
this study's statistical power was 100.00% for detecting a medium effect. Additionally, 
the power exceeded .99 for the detection of a moderate to large effect size. Thus, there 
was more than adequate power (i.e., power > .80) at the medium effect size level. 
Table 41 




Because none of the indicators reached significance in the Chi-square tests, no 
binomial logistic regression was conducted to test whether those variables remained 
significant after accounting for demographics.  
Answers to Research Question 4 
Analysis of the results of the chi-square test showed no association between the 
transgender group and either of the variables, thus no multivariable analysis (logistic 
regression) was conducted. This evidence suggests that the null hypothesis should not be 
rejected. 
Summary 
Section 3 included the results and findings of this research project. This section 
included an introduction, organization overview, data descriptive statistics and 
demographics, statistical assumptions, statistical analysis, and question summaries. This 
research analyzed the BRFSS datasets from 2014 to 2018 and focused on the transgender 
population's health and receipt of care including several dependent variables and 
covariates. 
Research Question 1 
RQ1– Is there a significant difference regarding perceived health and receipt of 
preventative care between transgender and non-transgender adults in the U.S.? 
Analysis of the chi-square test showed statistical significance in the association of 
the transgender group and influenza vaccination status (Cramer’s V = .007, p < .033) 
where more cisgender (46.5%) than transgender (41.5%) had received an influenza 
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vaccination within the past twelve months. However, the logistic regression revealed that 
influenza status was not significant when analyzed within demographics. The regression 
model indicated that Other race only, non-Hispanic in the demographic group was 
statistically significant. Citing these results, the null hypothesis should be rejected for this 
research question. 
Research Question 2 
RQ2– Is there a significant difference regarding perceived health and receipt of 
preventative care between transgender male-to-female (MtF) and female-to-male (FtM) 
transgender adults? 
Results of this chi-square test demonstrated a statistically significant association 
between transgender groups and pneumonia vaccination status (Cramer’s V = .134, p < 
.015) and the BLR showed that the MtF group (49.0%) was more than twice as likely 
[OR = [2.231], 95% CI (1.182, 4.211)] to receive a pneumonia vaccination than someone 
in the FtM group (35.5%). This evidence suggests that the null hypothesis should be 
rejected. 
Research Question 3 
RQ3- Are there significant differences between the MtF and FtM transgender 
adults in the frequency of medical treatments pursued by those with substantial chronic 
medical issues? 
The results of the chi-square test suggested the association of the transgender 
group and three variables were statistically significant in that the MtF group consistently 
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reported lower rates for all three chronic condition dependent variables; arthritis (28.6%), 
depression (18.0%), and diabetes (14.5%), and the FtM rates for the same were higher: 
arthritis (43.1%), depression (27.7%), and diabetes (21.3%). The regression analysis 
suggested that none were significant past demographics: arthritis, (beta = -.350, Wald = 
2.181, N.S.); depression, (beta = -.306, Wald = 1.247, N.S.); and diabetes, (beta = .425, 
Wald = 2.184, N.S.). Therefore, the null hypothesis should be rejected. 
Research Question 4 
RQ4- In the adult population, is there a significant difference regarding perceived 
satisfaction of care and the number of medical appointments conducted between MtF 
transgender, the FtM transgender, and the non-transgender communities? 
Analysis of the chi-square test results suggests no association between the 
transgender group and either of the variables. This evidence implies that the null 
hypothesis should not be rejected. 
A complete analysis and interpretation of results will be included in Section 4. 
This final section includes an overview of the analyses, limitations of the study, 
recommendations, applications to theory and literature, and social change opportunities. 
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Section 4: Application to Professional Practice and Implications for Social Change  
Purpose and Nature of the Study and Why it was Conducted 
This research focused on transgender individuals’ perceived health status and 
whether perceived health was a significant factor in prompting an individual to engage in 
preventative care. The transgender population has increased over time, which could be 
due to surveys that now include transgender questions or an actual increase in the 
transgender population. Either way, more transgender people are counted annually, and 
no studies have addressed the perception of care and individual actions based on those 
perceptions. This research effort investigated this situation in an attempt to address the 
following four research questions. 
Concise Summary of Key Findings 
In RQ1, the chi-square test indicated statistical significance in the association of 
the cisgender group and influenza vaccination status, but the logistic regression did not 
confirm that beyond demographics. In RQ2, the chi-square test showed a statistically 
significant association between the MtF group and pneumonia vaccination status, which 
was confirmed with the BLR. RQ3 yielded an association between the FtM group and 
three variables: Arthritis, depressive disorder, and diabetes were statistically significant, 
but the regression analysis suggested that none were significant beyond demographics. 
Finally, RQ4 suggested no statistically significant associations among any of the three 
gender groups and either of the variables. 
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Interpretation of Findings 
This study provides insight into how the perception of their health affects 
transgender people in pursuit of preventative care. Results by research question provide 
unique insights as each research question worked from different sample sizes as seen in 
Table 19 within the BRFSS data.  
Transgender Perceived Health 
In research question one, where perceived health and treatment sought between 
the cisgender and transgender community was investigated, there was a significant 
difference in the uptake of the preventative measure of Flu Vaccine within the Past 12 
Months, that is significantly more cisgender individuals received the influenza vaccine 
compared to transgender participants. Between the MtF and FtM subgroups, the same 
question was pursued in RQ2, and there is evidence that although none of the perceived 
health variables were significant, there was one significant association, MtF individuals 
obtaining a pneumonia vaccination. Cruz (2014) identified that nearly half of the 
transgender people surveyed failed to seek healthcare in contrast to the cisgender 
population that delayed at a rate of approximately 20%. 
Hobster and McLuskey (2020) reported that transgender people generally avoid 
healthcare. Additionally, there is a gap in the literature on transgender individuals and 
their perception of vaccinations. These results suggest congruence with the current 
literature.  
Transgender and Mental Health 
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Research questions one and two addressed perceived mental health. In the 
literature, Rowe et al. (2019) stated a high prevalence of low self-esteem amongst 
transgender people; however, this was not supported by the present investigation. The 
results suggest no statistically significant difference between MtF and FtM transgenders 
and transgender and cisgender people regarding perceived mental health. This research 
also supports that there is no statistically significant difference between MtF, FtM, and 
cisgender people in the pursuit of healthcare of any kind, which includes both physical 
and mental health needs. 
Other research efforts support the association of worse mental health outcomes 
for FtM transgender people with low income, less education, discrimination, and intimate 
partner violence (McDowell et al., 2019). However, these same determinants affect the 
general population (Chenyu Zhou et al., 2018), which aligns with the results presented 
here. These findings suggest that the determinants mentioned above are not significant 
factors in determining mental health conditions in transgender people. 
Preventative Health Care 
The transgender community has traditionally been seen as one population but is 
now studied like other groups in our population, as subgroups with specific needs and 
behaviors. This research sought to examine a specific gap in the community, the 
preventative care behaviors of transgender individuals by subgroup. One aspect of this 
research, vaccinations, had yielded insight into the communities’ preventative healthcare 
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behaviors. Study results revealed that significantly fewer transgender participants 
received influenza vaccination compared to cisgender participants. 
Likewise, in research question two, MtF group (49.0%) was more than twice as 
likely [OR = [2.231], 95% CI (1.182, 4.211)] to receive a pneumonia vaccination than 
someone in the FtM group (35.5%). These conclusions highlight the community's need to 
address preventative health needs as subgroups and not one mass of people. The research 
suggests different preventative health behaviors associated with various transgender 
subgroups and clinicians need to understand these differences to adequately address an 
individual’s healthcare needs. This finding is supported by McRee et al. (2018) in that 
preventative care is unique to transgender subgroups and a necessary part of an 
individual’s overall healthcare needs. 
Transgender  and HIV/AIDS 
Rowe et al. (2019) argue that more than 50% of HIV cases in the U.S. are among 
MtF individuals and men who have sex with men. The prevalence of HIV in the 
transgender community is substantial. However, the present study revealed no 
statistically significant testing behaviors among MtF, FtM, and cisgender individuals. 
This finding suggests further research into Mandsager et al.'s (2018) findings, who 
observed that disparities in HIV prevalence between cisgender men and transgender 
individuals are in decline.  
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Interpretation of Results within the Theoretical Framework 
The health belief model was used in this research effort to investigate whether 
health-related behavior in the transgender population was associated with perceived 
health conditions. The perceived health condition could be any, any combination of, or all 
four of the HBM components of perceived susceptibility, perceived severity, perceived 
benefits, or perceived barriers. The independent variable for this research effort was 
gender, specifically MtF, FtM, or cisgender. The study was controlled for the 
demographic variables. 
Research Question 1 
The findings in RQ1 support the HBM because the analysis of the chi-square test 
results showed the association of the cisgender group and influenza vaccination status as 
statistically significant. The perceived health status in the cisgender group was a 
significant predictor for action. The HBM requires one, or all, of the perception factors to 
influence an individual and lead them to take action in their health. The components in 
the HBM significantly predicted the likelihood that a cisgender individual would seek 
preventative care based on their perceived health situation. 
Research Question 2 
The findings of RQ2 supported the HBM. One preventative measure, pneumonia 
vaccination, was statistically significant in the MtF group with (n = 95, 49%) compared 
to the FtM group (n = 49, 35.5%). This result was confirmed for demographics through 
the completion of the BLR. The components in the HBM significantly predicted the 
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likelihood that a MtF person would seek preventative care based on their perceived health 
situation. 
Research Question 3 
Analysis of the results of the chi-square test showed the association of the FtM 
group and three severe disease measures, arthritis χ2 (1, N = 513) = 11.349, p = .001, 
depressive disorder χ2 (1, N = 513) = 6.774, p = .009, and diabetes χ2 (1, N = 513) = 
4.005, p = .045. The perceived health status in the FtM group was a significant factor. All 
other diseases for FtM and all disease categories for MtF were found not significant. The 
HBM requires one, or all, of the perception factors to influence an individual and lead 
them to take action in their health. The variables that represent the actions for RQ3 
included Length of time since last routine checkup and Doctor visits past 12 months. 
Length of time since last routine checkup between MtF (n = 271, 87.1%) and FtM 
(n = 180, 89.1%) was not significant. Doctor visits past 12 months was also not 
significant between MtF (n = 277, 89.1%) and FtM (n = 180, 89.1%). The results do not 
support nor rule out an individual’s perceived health situation as a factor in them seeking 
care. 
Research Question 4 
The findings of RQ4 did not support the HBM. Both variables were related to 
perceived barriers and were not significant in either the MtF, FtM, or cisgender 
populations. The components in the HBM did not significantly predict the likelihood that 
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a transgender individual would seek preventative care based on the perceived barriers in 
the HBM. 
Limitations of the Study 
The BRFSS datasets are the most comprehensive and current data to include the 
latest demographic data on the transgender community. These data represent adults in the 
U.S. who are over 18 years old who responded to the survey on either a landline or cell 
phone. The BRFSS is considered the best representative sample that addresses behavioral 
health risk today. Therefore, this research project is representative of the transgender 
community to the point of a general subgroup. That means MtF, FtM, or gender non-
conforming without regard to gender-confirming surgery or gender-confirming medical 
treatment. Another limitation is that this research cannot account for nor properly 
represent an individual who is gender fluid and has identified as more than one gender in 
the BRFSS in any year. 
Additionally, this project does not distinguish between transgender people in 
either a pretransition, post-transition, or declined transition status. Some transgender 
people elect gender confirming treatment, including hormonal and surgical support, but 
this study does not differentiate these individuals as that information is not available in 
the data. 
Recommendations 
Based on the results of this study, I would recommend that additional research be  
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conducted to determine if similar or differing results can be established within the 
transgender community throughout the United States and abroad. Many countries 
worldwide use the BRFSS template and format; this creates an excellent opportunity to 
use it as a source for data that would invite a standardized approach to research the 
transgender community. Additionally, future research would be better served through the 
inclusion of additional transgender subgroup clarification. 
An example of this additional clarification includes defining distinct subgroups, 
including defining anatomical and physiological distinctions as pre- or post-gender 
confirming surgery. Another distinction should include individuals who receive gender-
confirming hormone therapy and how far along they are in the treatment. Additionally, 
subgroups should detail a chronology and gender an individual has identified as 
throughout their lifetime. At a minimum, it would be necessary for a researcher to 
understand how many genders an individual has identified as and if they have undergone 
one or more confirming surgeries. 
It would be advantageous for future researchers to conduct a mixed-methods 
study to include quantitative and qualitative variables to assess perceived health within a 
subjective context. Researchers would benefit from individual interviews where they 
could query participants about their motivation for seeking preventative care, 
highlighting the self-efficacy component to give insight to an individual’s cue to action in 
context with the other components of the health belief model. 
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A final recommendation is to evaluate transgender people with both natal sexes in 
both physical and mental health issues. For example, MtF should be researched not only 
with female, but male and FtM should be evaluated with not only natal male, but female 
at the same time. Much research pairs MtF with women and FtM with men, but this limits 
the insights to be gleaned through a more in-depth analysis. Transgender subgroup 
analysis can benefit from pairing with cisgender subgroups. 
Implications for Professional Practice and Social Change 
This section provides recommendations to professional practice and positive 
social change implications relevant to perceived health in the transgender community. A 
growing count of transgender people offers an opportunity to engage a broader 
population and better understand minority health. 
Implications for Professional Practice 
The findings include a significant association between the cisgender group and 
influenza vaccination status in RQ1and a significant positive association between MtF 
individuals and pneumonia vaccinations in RQ2. Edmiston et al. (2016) identified in their 
metanalysis that they included no studies of transgender individuals and influenza 
vaccinations and none were found during the literature review. These findings also help 
to address the unique immunization needs faced by the transgender community (Imborek 
et al., 2017).  
Additionally, the association between FtM individuals and the following diseases, 
arthritis, depressive disorder, and diabetes, was significant. These results confirm 
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previous work in the association of FtM individuals with arthritis and depression but is 
different in previous research where MtF with diabetes have been identified as more 
prevalent, but the difference referenced in that research was not significant (Downing & 
Przedworski, 2018). These results are also important because these significant results 
expand professional knowledge regarding limited research pertaining to transgender 
preventative healthcare (McRee et al., 2018). 
As a new and emerging demographic group, not many resources are available to 
conduct public health research, but the BRFSS is one resource that could be of assistance. 
The BRFSS is an excellent resource for secondary data, allowing researchers to research 
the transgender community. The BRFSS is the largest and most extensive survey 
conducted that collects data on transgender individuals. Many countries around the world 
use the BRFSS format and are becoming more comprehensive in their collection. 
This vast resource is a very cost effective manner in conducting meaningful 
research to better understand the behaviors, perceptions, and health outcomes of the 
transgender population. This annual survey is valuable because future surveys offer 
insight into today’s interventions and procedures' effectiveness. New questions are added, 
and new gender categories can be added to better specify individuals in the subgroups, 
allowing practitioners to better target treatments and interventions. 
Implications for Theoretical Framework 
In this project, the HBM was used as a theoretical framework. Rosenstock (1974) 
observed that this framework is not a good fit for cross-sectional data because 
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perceptions change over time. This change may impact behavior, thereby supply 
inconsistent results. Additionally, the complication of the fluidity of gender identification 
was not controlled and may play an essential factor in this research. Gender fluidity is 
where an individual identifies as one transgender subgroup in one year of the BRFSS, 
followed by another year where that same individual identifies as a different subgroup. 
The unknown history of an individual is potentially disruptive in collecting accurate data. 
Patrão et al. (2018) report health-related perceptions are associated with gender. 
Researchers must consider the fluidity of gender for future investigations and include that 
variable appropriately or control for it as required. Gender fluidity was not measured in 
this research and because research supports that perceived health is associated with 
gender, the changing perceptions would supply inconsistent results in this research that 
would not be identified. Tacikowski and Ehrsson (2020) noted that gender is a dynamic 
element and considered it robust. Gender fluidity must be included in future iterations of 
the BRFSS and other surveys. 
This research effort did not identify individuals as having completed gender-
confirming surgery or the utilization of gender-specific hormone therapy. Both of these 
gender-confirming factors have considerable impacts on anatomy and physiology, 
respectively. These factors may also play a significant role in an individual’s perception 
of their health situation and should be considered for future research as no supporting 
research is available. 
Positive Social Change 
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The HBM was selected as a theoretical framework for this research to illustrate 
the specific healthcare needs within the transgender community. To properly identify 
interventions and best health practices for a community, professionals must become 
educated and understand the specifics of the subgroups in the population and the unique 
perceived barriers and modifying variables they experience to correctly provide the most 
beneficial treatments. This project supports positive social change by assisting healthcare 
professionals better understand the specific preventative healthcare needs in the 
subgroups in the transgender community. A better understanding of health behaviors and 
needs helps healthcare professionals better design prophylaxis and preventative 
treatments built into health policy and proliferated throughout the community. In this 
way, the findings will assist policymakers, epidemiologists, community planning group 
members, and other key stakeholders in determining at-risk transgender people by 
subgroup in the population. 
Conclusion 
This study identified significant differences in preventative healthcare needs and 
treatment between the transgender and cisgender communities or transgender subgroups. 
These findings are consistent with recent conclusions for HIV-positive transgender and 
cisgender males (Mandsager et al., 2018). Perceived health and preventative care 
measures were analyzed in a binomial logistic regression model; only pneumonia 
vaccination remained statistically significant between MtF and FtM adults. All others 
were not statistically significant. 
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This research included five years of data from the BFRSS; however, the CDC first 
collected data pertaining to the transgender group in the BRFSS in 2014 and should 
continue to mature and become better defined. A highly demarcated sample with other 
transgender subgroups can offer additional insight into the perceived health concerns 
within the transgender community. Many countries use the BRFSS as a template for their 
behavioral and health data collection; the opportunity to glean insights at the international 
level is possible. 
The transgender community is still being defined because of numerous factors, 
including the fluidity of gender, which necessitate that when researchers address analysis, 
they consider innovative ways to capture unpredictable data sources. This research 
project was limited in this manner as the BRFSS does not have the needed subgroup 
variables to achieve that granularity of analysis. Future research must address the need to 
collect multiple gender data points on some people. In this manner, researchers and 
health care professionals can offer opportunities to improve their understanding and 
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